Other spirochaetal diseases

AB1_OTHER_SPIROCHAETAL

Pinta: An infectious disease of the skin caused by Treponema carateum that occurs only in the western hemisphere. Age of onset is between 10 and 20 years of age. This condition is characterized by marked changes in the skin color and is believed to be transmitted by direct person-to-person contact.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A65-A69 Hospital discharge: ICD-9 — 104\|08[7-7] Hospital discharge: ICD-8 — 08[8-9] Cause of death: ICD-10 — A65-A69 Cause of death: ICD-9 — 104\|08[7-7] Cause of death: ICD-8 — 08[8-9] 2 out of 7 registries used, show all original rules.	4177
4. Check minimum number of events None	4177
5. Include endpoints AB1_SYPHILIS_NONVENEREAL AB1_YAWNS AB1_PINTA AB1_RELAP_FEVER AB1_SPIROCHE_OTHER AB1_LYME	18036
6. Filter based on genotype QC (FinnGen only)	16508

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	AB1_OTHER_SPIROCHAETAL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	AB1_SYPHILIS_NONVENEREAL\|AB1_YAWNS\|AB1_PINTA\|AB1_RELAP_FEVER\|AB1_SPIROCHE_OTHER\|AB1_LYME
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A6[5-9]
HD_ICD_9	104\|08[7-7]
HD_ICD_8	08[8-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A6[5-9]
COD_ICD_9	104\|08[7-7]
COD_ICD_8	08[8-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other spirochaetal diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16508	10369	6139
Unadjusted period prevalence (%)	3.36	3.68	2.81
Median age at first event (years)	63.29	62.29	64.97

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17106: Matched controls
171059

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

4.5

307.7

1084

2561

A69.2

ICD-10 Finland

Lyme disease

318137.9

307.7

16679

J01CA04

ATC

amoxicillin; systemic

4.0

307.7

15557

122700

S12

ICPC

Insect bite/sting

7.5

307.7

4387

7518

M01.2*A69.2

ICD-10 Finland

Arthritis in Lyme disease

116.8

272.8

139

S29

ICPC

Skin symptom/complaint other

1.7

178.6

3818

24224

G63.0*A69.2

ICD-10 Finland

Polyneuropathy (in) Lyme disease

355.0

175.7

177

S73

ICPC

Pediculosis/skin infestation other

11.8

173.3

176

150

S72

ICPC

Scabies/other acariasis

4.9

161.4

362

755

J01AA02

ATC

doxycycline; systemic

1.6

149.8

13183

115132

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

131.7

3818

25919

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

124.6

3699

25208

G01*A69.2

ICD-10 Finland

Meningitis (in) Lyme disease

1217.7

124.1

121

TAB00

NOMESCO Finland

Lumbar puncture

2.3

107.1

831

3677

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

94.2

3218

22444

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

92.6

2276

14700

S13

ICPC

Animal/human bite

2.4

90.1

668

2896

A98

ICPC

Health maint/preventive medicine

2.8

86.7

16757

161486

M25.5

ICD-10 Finland

Pain in joint

1.4

84.4

5512

43352

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

84.3

674

3018

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

84.2

2941

20549

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

84.1

1340

7675

SPAT1262

SPAT

Handing over of treatment supplies

0.5

82.1

1056

18665

1048A

ICD-9 Finland

Other spirochaetal infection, Other specified spirochaetal infections[MORBUS LYME]

+∞

81.3

103

Kela drug reimbursment

Diabetes, insulin-treated

0.6

80.3

2068

30590

SPAT1152

SPAT

Removal of foreign body from under the skin

2.7

77.9

439

1672

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

77.4

4890

38117

Z2221

NOMESCO Finland

Medical doctor

1.4

72.6

4136

31607

S08

ICPC

Skin colour change

1.9

72.0

916

4880

S06

ICPC

Rash localized

1.9

71.1

933

5022

B88.0

ICD-10 Finland

Other acariasis

6.3

70.9

118

187

L57.0

ICD-10 Finland

Actinic keratosis

1.6

67.9

1563

9884

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.7

64.5

2047

29179

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

64.2

7981

68340

A10BA02

ATC

metformin; oral

0.7

59.4

2407

32824

N73

ICPC

Neurological infection other

18.4

57.7

205

Kela drug reimbursment

Chronic hypertension

0.7

54.8

1940

27194

SPAT1324

SPAT

Screening procedure

0.6

54.7

1301

19802

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.7

54.6

1923

26986

C03CA01

ATC

furosemide; systemic

0.7

52.1

2269

30669

M04AB01

ATC

probenecid; oral

10.6

49.6

T90

ICPC

Diabetes non-insulin dependent

0.7

49.4

2125

28824

G51.0

ICD-10 Finland

Bell palsy

2.2

49.2

421

1937

D22

ICD-10 Finland

Melanocytic naevi

1.7

49.0

864

5078

R83

ICPC

Respiratory infection other

1.3

48.8

3848

30624

M01AH05

ATC

etoricoxib; oral

1.3

47.0

10130

91366

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

46.6

3529

27891

D19

ICPC

Teeth/gum symptom/complaint

1.3

46.0

4818

39801

L548, A692,

ICD-10 Finland

+∞

45.8

S21

ICPC

Skin texture symptom/complaint

1.4

45.3

2327

17291

A68.9

ICD-10 Finland

Relapsing fever, unspecified

230.6

45.0

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

44.3

3948

31889

M79.6

ICD-10 Finland

Pain in limb

1.3

44.3

7001

60735

WX725

NOMESCO Finland

Noninvasive ventilation

0.4

44.1

213

5417

Z01.7

ICD-10 Finland

Laboratory examination

1.4

43.7

2557

19405

A10AE04

ATC

insulin glargine; parenteral

0.5

43.6

496

9201

Z71.8

ICD-10 Finland

Other specified counselling

1.3

42.2

5266

44351

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.7

41.7

2249

29505

WW200, ,

SPAT

1.3

40.8

4645

38650

H02

ICPC

Hearing complaint

1.4

40.4

2103

15643

WX720

NOMESCO Finland

Own respiration

0.4

39.9

173

4619

J01FA10

ATC

azithromycin; systemic

1.2

39.5

8985

80752

R06AX27

ATC

desloratadine; oral

1.3

39.1

4342

35977

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

36.5

5397

46162

H02AB07

ATC

prednisone; oral

1.4

36.2

1854

13735

D01AE16

ATC

amorolfine; topical

1.4

35.8

1611

11672

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

0.7

34.8

1265

17807

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

34.4

1061

7141

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.9

34.2

405

2104

R01AD09

ATC

mometasone; nasal

1.2

34.2

6953

61389

A97

ICPC

No disease

1.3

33.8

2952

23658

A23

ICPC

Risk factor NOS

1.4

33.8

1396

9954

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

33.6

723

4476

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

0.6

33.5

647

10410

GD1AA, ,

SPAT

1.3

33.4

2373

18482

A10AC01

ATC

insulin (human); parenteral

0.5

33.3

304

6061

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

32.9

3306

26961

WX704

NOMESCO Finland

Intubation

0.6

32.9

502

8579

SPAT1254

SPAT

Administration of medicine

0.7

32.7

993

14471

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.5

32.1

344

6514

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

32.0

813

5240

A10AB05

ATC

insulin aspart; parenteral

0.5

31.9

384

7018

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

31.7

1869

14143

I50.9

ICD-10 Finland

Heart failure, unspecified

0.6

31.3

705

10948

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

0.7

30.8

944

13743

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

30.7

1537

11328

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.4

30.4

202

836

D01BA02

ATC

terbinafine; oral

1.3

30.3

3642

30308

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

0.5

30.2

258

5262

J01DB01

ATC

cefalexin; oral

1.2

30.2

13323

126288

S82

ICPC

Naevus/mole

1.3

30.1

2061

15944

H93.1

ICD-10 Finland

Tinnitus

1.5

29.9

1016

6973

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

29.7

4082

34463

C01CA24

ATC

epinephrine; parenteral

1.5

29.7

855

5669

H10

ICD-10 Finland

Conjunctivitis

1.5

29.4

1019

7021

SPAT1249

SPAT

Treatment-related counselling outside office

0.8

29.4

4243

49500

R01AD08

ATC

fluticasone; nasal

1.2

29.3

4170

35338

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

29.3

1521

11276

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

29.2

693

4395

SPAT1222

SPAT

Counselling/guidance promoting independent living

0.7

28.8

1046

14757

TPH07

NOMESCO Finland

Cathetrisation of artery

0.7

28.6

780

11636

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

28.5

1415

10409

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

28.5

3678

30820

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.6

28.4

718

10884

EB1AA, ,

SPAT

1.5

28.1

910

6183

V18

ICD-10 Finland

Pedal cyclist injured in noncollision transport accident

3.1

28.1

117

380

R05

ICD-10 Finland

Cough

1.3

28.1

3167

26126

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

0.7

28.1

1255

17085

D06BB10

ATC

imiquimod; topical

1.6

27.9

707

4556

Z51.5

ICD-10 Finland

Palliative care

0.6

27.4

479

7905

SPAT1263

SPAT

Sampling

0.8

27.3

4625

53203

A28

ICPC

Limited function/disability NOS

0.7

27.1

1296

17460

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

26.6

1248

9088

I50.0

ICD-10 Finland

Congestive heart failure

0.5

26.6

250

4936

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

26.3

6349

56518

130

Kela drug reimbursment

Malignant tumour

0.6

26.3

514

8256

L17

ICPC

Foot/toe symptom/complaint

1.2

26.0

4593

39699

J05AB11

ATC

valaciclovir; oral

1.3

26.0

2076

16391

HA1RA, ,

SPAT

1.6

25.9

672

4354

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

0.4

25.7

172

3831

W86

ICD-10 Finland

Exposure to other specified electric current

3.3

25.6

293

OAB50, ,

SPAT

0.6

25.6

540

8522

X58

ICD-10 Finland

Exposure to other specified factors

1.3

25.6

2065

16323

M01.2

ICD-10 Finland

Arthritis in Lyme disease

44.3

25.5

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.6

25.4

484

7824

R74

ICPC

Upper respiratory infection acute

1.2

25.2

4824

41986

M79.1

ICD-10 Finland

Myalgia

1.3

25.2

2128

16917

R51.80

ICD-10 Finland

Headache

1.3

25.2

2178

17367

R4110

NOMESCO Finland

Physiotherapy

1.2

25.2

3952

33734

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

25.0

1742

13490

Z20.7

ICD-10 Finland

Contact with and exposure to pediculosis, acariasis and other infestations

4.7

24.9

122

B35.1

ICD-10 Finland

Tinea unguium

1.5

24.8

944

6621

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

24.8

1198

8768

S18

ICPC

Laceration/cut

1.2

24.4

7098

64084

SPAT1097

SPAT

Recording of ECG

0.7

24.3

1109

15067

R52.9

ICD-10 Finland

Pain, unspecified

1.3

24.2

1478

11225

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

24.0

4504

39092

F29

ICPC

Eye symptom/complaint other

1.3

23.9

1522

11628

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

0.6

23.8

393

6588

PH2AE, ,

SPAT

1.9

23.8

310

1665

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

23.6

1373

10348

A10BB12

ATC

glimepiride; oral

0.5

23.6

252

4774

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

23.4

3384

28612

B02

ICD-10 Finland

Zoster [herpes zoster]

1.6

23.4

599

3870

N05AX08

ATC

risperidone; systemic

0.6

23.2

425

6941

0879X

ICD-9 Finland

Relapsing fever, unspecified

+∞

22.9

A06AD11

ATC

lactulose; oral

0.7

22.9

974

13393

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

22.7

7358

66887

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

22.7

2824

23490

H81

ICPC

Excessive ear wax

1.3

22.7

2313

18808

M01AE02

ATC

naproxen; oral, rectal

1.2

22.6

8519

78372

A10BH01

ATC

sitagliptin; oral

0.7

22.6

614

9180

G04CA01

ATC

alfuzosin; oral

1.3

22.6

1345

10172

L08

ICPC

Shoulder symptom/complaint

1.2

22.5

3384

28711

M03BX02

ATC

tizanidine; oral

1.2

22.5

9701

90208

SDA03

NOMESCO Finland

Periodontal treatment

1.2

22.4

6207

55687

N02AA05

ATC

oxycodone; systemic

0.8

22.3

1490

19142

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

3.9

22.1

160

A69.9

ICD-10 Finland

Spirochaetal infection, unspecified

52.1

22.1

R51

ICD-10 Finland

Headache

1.5

21.7

750

5162

J20

ICD-10 Finland

Acute bronchitis

1.3

21.5

1443

11110

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.3

21.1

1274

9656

N05AA02

ATC

levomepromazine; systemic

0.4

21.0

140

3119

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

20.9

1323

10093

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

0.7

20.9

549

8267

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

20.9

1092

8091

UDC00

NOMESCO Finland

Ear microscopy

0.6

20.9

449

7060

L30

ICD-10 Finland

Other dermatitis

1.8

20.7

325

1850

K08.80

ICD-10 Finland

Toothache NOS

1.3

20.6

1246

9447

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

0.5

20.4

178

3603

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

20.3

1900

15275

F38

ICPC

Eye, Other laboratory test NEC

1.9

20.2

241

1260

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

20.1

2272

18680

SPAT1301

SPAT

No procedures

0.8

19.9

3177

37005

TPH04

NOMESCO Finland

Cathetrisation of vein

0.8

19.9

2128

25822

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

19.8

611

4110

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.6

19.7

449

2823

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.4

19.6

778

5499

G63.0

ICD-10 Finland

Polyneuropathy in infectious and parasitic diseases classified elsewhere

28.9

19.6

A10AE05

ATC

insulin detemir; parenteral

0.5

19.5

242

4381

H01.0

ICD-10 Finland

Blepharitis

1.4

19.4

932

6812

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

19.2

965

7106

Z01.2

ICD-10 Finland

Dental examination

1.2

19.0

7120

65137

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

18.9

1545

12206

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

18.9

6939

63367

R01AD58

ATC

fluticasone, combinations; nasal

1.2

18.8

3571

30905

L15

ICPC

Knee symptom/complaint

1.2

18.7

3701

32148

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.3

18.7

1197

9147

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

18.7

1330

10316

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.3

18.6

1137

8629

EB1SA, ,

SPAT

1.5

18.5

676

4704

I78.1

ICD-10 Finland

Naevus, non-neoplastic

1.8

18.5

290

1653

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.4

18.4

688

4812

M54

ICD-10 Finland

Dorsalgia

1.3

18.2

1683

13503

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.6

18.2

338

5499

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

18.2

797

5734

L01

ICPC

Neck symptom/complaint

1.2

17.9

2300

19157

SPAT1100

SPAT

Long-term monitoring of blood pressure

0.6

17.7

322

5267

F02.89*A69.2

ICD-10 Finland

Dementia in Lyme disease

+∞

17.7

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

17.7

3931

34467

SPAT1304

SPAT

Counselling and guidance related to ageing

0.6

17.7

337

5447

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

1.9

17.6

233

1261

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

17.6

378

5943

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

17.4

3284

28374

N05AH03

ATC

olanzapine; systemic

0.6

17.4

360

5712

L03

ICPC

Low back symptom/complaint

1.2

17.3

4247

37528

M67.4

ICD-10 Finland

Ganglion

1.4

17.3

913

6774

EBA15

NOMESCO Finland

Extraction of multiple teeth

0.5

17.3

167

3264

NG2AA

NOMESCO Finland

Patella X-ray examination

1.6

17.3

370

2294

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

17.2

14687

142472

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

0.6

17.1

389

6038

H92.0

ICD-10 Finland

Otalgia

1.4

17.0

835

6123

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.3

17.0

1463

SPAT1193

SPAT

Pap smear

0.7

17.0

607

8612

Z04.3

ICD-10 Finland

Examination and observation following other accident

1.8

17.0

249

1392

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

0.8

16.9

1391

17435

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

16.9

5282

47547

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

16.8

350

5541

A04AA02

ATC

granisetron; systemic, transdermal

0.6

16.7

421

6393

XX3DW

NOMESCO Finland

Time consuming IT work

0.7

16.6

835

11201

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.5

16.5

496

3322

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.4

16.4

777

5664

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

16.4

581

4021

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.5

16.3

574

3969

L13

ICPC

Hip symptom/complaint

1.2

16.3

2735

23371

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

0.5

16.2

177

3324

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

16.0

3650

32026

R42

ICD-10 Finland

Dizziness and giddiness

1.2

16.0

3096

26790

-31

ICPC

Medical examin/health eval partial

0.6

15.9

386

5909

A10BK03

ATC

empagliflozin; oral

0.7

15.9

806

10799

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.3

15.9

1169

9106

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

15.9

4703

42122

TK800

NOMESCO Finland

Hemodialysis

0.3

15.8

1498

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

2.1

15.7

153

747

R00.2

ICD-10 Finland

Palpitations

1.3

15.6

1070

8252

G01

ICD-10 Finland

Meningitis in bacterial diseases classified elsewhere

160.1

15.5

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

15.4

4273

38058

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

15.4

2708

23223

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

0.6

15.4

336

5263

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

15.4

1528

12356

SPAT1245

SPAT

Provision of support and information to patient’s family members

0.5

15.4

128

2626

L53.8

ICD-10 Finland

Other specified erythematous conditions

3.2

15.4

194

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

0.8

15.4

1436

17740

A10BB01

ATC

glibenclamide; oral

0.4

15.3

1785

G44.2

ICD-10 Finland

Tension-type headache

1.2

15.3

1846

15257

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.6

15.3

233

3979

ZX080

NOMESCO Finland

Image guided radiotherapy

0.4

15.2

1617

OAB95, ,

SPAT

1.3

15.2

998

7652

SPAT1148

SPAT

Treatment of chronic ulcer or burn

0.8

15.2

980

12681

SPAT1229

SPAT

Assessment of need for aid

0.7

15.1

446

6558

N17.9

ICD-10 Finland

Acute renal failure, unspecified

0.5

15.1

170

3161

CS494

NOMESCO Finland

Other visual field testing

1.6

15.0

317

1959

R06AX22

ATC

ebastine; oral

1.2

15.0

2326

19717

NH3AA, ,

SPAT

1.4

15.0

724

5299

J18.9

ICD-10 Finland

Pneumonia, unspecified

0.8

14.9

2343

27444

WX002

NOMESCO Finland

Sedation and analgesia

1.2

14.9

2468

21051

HARJA, ,

NOMESCO Finland

3.2

14.8

173

L54.8

ICD-10 Finland

Erythema in other diseases classified elsewhere

12.4

14.8

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.4

14.8

579

4084

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.3

14.8

1277

10152

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

0.5

14.8

157

2973

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

1.7

14.7

239

1379

OAA67, ,

SPAT

1.2

14.7

2238

18937

J01MA01

ATC

ofloxacin; systemic

1.3

14.6

916

6979

H48.1*A69.2

ICD-10 Finland

Retrobulbar neuritis in Lyme disease

+∞

14.6

M75

ICD-10 Finland

Shoulder lesions

1.4

14.6

568

4005

F45.8

ICD-10 Finland

Other somatoform disorders

1.3

14.6

838

6304

H02AB02

ATC

dexamethasone; systemic

0.8

14.5

980

12606

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.3

14.5

1323

HMAK, ,

NOMESCO Finland

0.8

14.5

925

11989

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

1.9

14.4

173

909

SPAT1360

SPAT

Extensive global examination

1.4

14.4

811

6082

A10AA02, ,

ATC

0.4

14.3

2111

A10BJ06

ATC

semaglutide; parenteral

0.6

14.3

338

5197

N30

ICD-10 Finland

Cystitis

1.3

14.2

1065

8318

WX780

NOMESCO Finland

Remote monitoring CPAP

0.6

14.2

260

4238

NG1BG, ,

SPAT

1.5

14.2

500

3461

H60

ICD-10 Finland

Otitis externa

1.4

14.1

667

4862

J01

ICD-10 Finland

Acute sinusitis

1.4

14.0

722

5337

L12

ICPC

Hand/finger symptom/complaint

1.2

14.0

2396

20484

SPAT1377

SPAT

Polysomnography

0.5

14.0

145

2764

M01AB05

ATC

diclofenac; systemic, rectal

1.1

13.9

10063

95373

A10BH05

ATC

linagliptin; oral

0.6

13.9

248

4068

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

0.3

13.9

1442

F29

ICD-10 Finland

Unspecified nonorganic psychosis

0.5

13.9

144

2743

R21

ICPC

Throat symptom/complaint

1.2

13.8

2827

24549

D01

ICPC

Abdominal pain/cramps general

1.2

13.8

1644

13563

WX110, ,

SPAT

1.4

13.7

709

5244

N18.8

ICD-10 Finland

Other chronic renal failure

0.4

13.7

1510

N17

ICPC

Vertigo/dizziness

1.2

13.7

1647

13600

SPAT1395

SPAT

Health check-up of persons outside student and working life

0.4

13.6

1890

G04CB01

ATC

finasteride; oral

1.3

13.6

980

7614

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.4

13.6

1442

WX723

NOMESCO Finland

CPAP therapy

0.6

13.4

257

4144

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.4

13.3

702

5209

A66.1

ICD-10 Finland

Multiple papillomata and wet crab yaws

18.2

13.3

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

0.4

13.3

1818

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

13.3

382

5643

L90.4

ICD-10 Finland

Acrodermatitis chronica atrophicans

11.4

13.3

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

13.2

4213

37833

A02BC04

ATC

rabeprazole; oral

1.3

13.2

1140

9064

H25.0

ICD-10 Finland

Senile incipient cataract

1.3

13.1

780

5896

R06AE07

ATC

cetirizine; oral

1.1

13.1

6412

59229

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

13.1

2681

23272

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

0.6

13.0

194

3331

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

13.0

938

11968

K30

ICD-10 Finland

Functional dyspepsia

1.2

13.0

1524

12553

I50.1

ICD-10 Finland

Left ventricular failure

0.6

12.8

187

3228

HA1AE, ,

SPAT

1.5

12.8

419

2859

S04

ICPC

Lump/swelling localized

1.2

12.8

1451

11905

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

0.6

12.8

231

3774

B01AB10

ATC

tinzaparin; parenteral

0.8

12.7

954

12110

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.2

12.7

1901

16042

R35

ICD-10 Finland

Polyuria

1.3

12.7

804

6134

J02AC02

ATC

itraconazole; systemic

1.2

12.7

2341

20134

A02BC05

ATC

esomeprazole; systemic

1.1

12.7

5827

53579

Z00.0

ICD-10 Finland

General medical examination

1.2

12.7

2540

22000

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

0.7

12.7

320

4853

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.5

12.7

434

2989

C03DA01

ATC

spironolactone; oral

0.8

12.6

935

11889

C09AA05

ATC

ramipril; oral

0.8

12.6

2300

26630

E66.01

ICD-10 Finland

Obesity due to excess calories

0.8

12.6

790

10266

XF400

NOMESCO Finland

ECG with 12 standard connections

1.2

12.6

1780

14939

M15

ICD-10 Finland

Polyarthrosis

1.4

12.6

631

4649

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.2

12.6

1701

14216

P72

ICPC

Schizophrenia

0.3

12.5

1313

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

12.5

1472

A10AB01

ATC

insulin (human); parenteral

0.5

12.5

129

2458

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.9

12.5

4757

52160

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.3

12.4

1233

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.8

12.4

1196

14741

M23

ICD-10 Finland

Internal derangement of knee

1.6

12.4

308

1982

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

1.8

12.4

177

985

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

1.6

12.4

259

1601

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

12.3

7713

72229

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.2

12.3

2504

21722

N05AD01

ATC

haloperidol; systemic

0.5

12.2

2018

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.2

12.2

1333

10895

R03BA02

ATC

budesonide; inhalant

1.2

12.2

2335

20149

J05AB01

ATC

aciclovir; systemic

1.2

12.1

2927

25729

A06AC51

ATC

ispaghula, combinations; oral

1.4

12.1

576

4207

EBA00

NOMESCO Finland

Extraction of tooth

0.9

12.1

4252

46889

H02AB04

ATC

methylprednisolone; systemic

1.2

12.0

1831

15473

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

12.0

6333

58666

N05AF03

ATC

chlorprothixene; systemic

0.5

12.0

1978

H61.2

ICD-10 Finland

Impacted cerumen

1.3

12.0

840

6499

H29

ICPC

Ear symptom/complaint other

1.2

12.0

1599

13339

J01MA06

ATC

norfloxacin; oral

1.2

12.0

1574

13112

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.5

11.9

414

2860

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

1.5

11.9

309

2011

J37.0

ICD-10 Finland

Chronic laryngitis

1.5

11.9

399

2739

I10

ICD-10 Finland

Essential (primary) hypertension

0.9

11.9

7853

83391

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.2

11.8

1278

10429

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.2

11.8

1390

11447

NE1AA, ,

SPAT

1.6

11.7

232

1414

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

0.5

11.7

113

2201

A10AE06

ATC

insulin degludec; parenteral

0.6

11.7

174

2986

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.3

11.7

1189

9637

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.8

11.7

1406

16926

MAX99

NOMESCO Finland

Assistance to normal delivery

1.3

11.7

675

5084

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

0.2

11.7

499

A06AC01

ATC

ispaghula (psylla seeds); oral

1.1

11.7

3570

31925

M77.4

ICD-10 Finland

Metatarsalgia

1.3

11.6

788

6072

OAB43, ,

SPAT

1.1

11.6

4065

36685

R07.3

ICD-10 Finland

Other chest pain

1.2

11.6

1315

10790

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.3

11.5

1120

9035

SPAT1139

SPAT

Nutrition survey

0.5

11.5

140

2536

R01AD12

ATC

fluticasone furoate; nasal

1.1

11.5

4410

40040

A84.8

ICD-10 Finland

Other tick-borne viral encephalitis

5.7

11.5

H22.0*A69.2

ICD-10 Finland

Iridocyclitis in Lyme disease

120.1

11.4

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.3

11.4

975

7742

XF402

NOMESCO Finland

ECG with work load test

1.2

11.4

1238

10108

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.3

11.4

912

7183

Z24.1

ICD-10 Finland

Need for immunization against arthropod-borne viral encephalitis

2.4

11.4

319

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

0.6

11.4

175

2975

S59

ICPC

Skin, Other therap proced/minor surg NEC

1.6

11.4

262

1659

T36

ICD-10 Finland

Poisoning by systemic antibiotics

0.6

11.4

219

3521

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

11.3

2971

26270

C10AA01

ATC

simvastatin; oral

0.9

11.3

4434

48610

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.1

11.3

3596

32237

A10BD07

ATC

metformin and sitagliptin; systemic

0.6

11.3

222

3552

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

0.6

11.3

216

3478

J45

ICD-10 Finland

Asthma

1.2

11.3

1348

11123

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.4

11.2

443

3135

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

0.5

11.2

111

2142

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

1.5

11.2

332

2223

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.9

11.2

2363

27056

XQ855

NOMESCO Finland

Skin temperature measurement

2.8

11.2

199

LX2A3, ,

SPAT

0.5

11.1

132

2410

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

11.1

1065

8576

M01AX05

ATC

glucosamine; oral

1.2

11.1

2345

20389

N05AH02

ATC

clozapine; systemic

0.4

11.1

1207

XF640, ,

NOMESCO Finland

1.6

11.1

273

1757

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.2

11.1

1463

12195

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

0.8

11.0

1072

13198

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.2

11.0

1413

11743

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

0.7

11.0

268

4086

A49.9

ICD-10 Finland

Bacterial infection, unspecified

0.8

10.9

847

10710

R03BC03

ATC

nedocromil; inhalant

1.3

10.9

820

6407

R50.9

ICD-10 Finland

Fever, unspecified

1.2

10.9

1894

16193

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.1

10.9

6202

57616

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

10.9

2884

25509

L57

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation

2.6

10.9

236

SPAT1079

SPAT

Echocardiography

0.2

10.9

826

ZY010, ,

SPAT

1.7

10.8

181

1056

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

1.8

10.8

142

771

QBE99, ,

SPAT

2.0

10.8

115

582

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.3

10.8

855

6725

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.3

10.8

756

5856

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

0.5

10.7

1829

H02AB06

ATC

prednisolone; systemic

1.1

10.7

6808

63631

N05BA06

ATC

lorazepam; systemic, sublingual

0.7

10.6

277

4169

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

10.6

1741

20364

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

0.2

10.6

450

R52.2

ICD-10 Finland

Other chronic pain

1.4

10.5

450

3231

OAB47, ,

SPAT

0.7

10.5

319

4655

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

10.5

1298

10749

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

0.5

10.4

1611

A69.0

ICD-10 Finland

Necrotizing ulcerative stomatitis

110.1

10.4

K03.66

ICD-10 Finland

Tooth plaque

1.3

10.4

972

7805

J01AA04

ATC

lymecycline; systemic

1.2

10.4

1606

13590

TUPEI, ,

NOMESCO Finland

1.4

10.4

413

2930

L29

ICPC

Musculoskeletal sympt/complt other

1.2

10.3

1143

9356

B01AF01

ATC

rivaroxaban; oral

1.2

10.3

1551

13092

SPAT1279

SPAT

Preparation of immediate hospitalisation

0.2

10.3

462

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.4

10.2

376

2628

M19

ICD-10 Finland

Other arthrosis

1.5

10.2

268

1749

B35.3

ICD-10 Finland

Tinea pedis

1.3

10.2

561

4194

K59.0

ICD-10 Finland

Constipation

1.3

10.2

641

4887

D23

ICD-10 Finland

Other benign neoplasms of skin

1.5

10.2

279

1837

J02AC01

ATC

fluconazole; systemic

1.1

10.2

5663

52474

D07AD01

ATC

clobetasol; topical

1.2

10.2

2253

19645

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.6

10.2

219

3434

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.6

10.2

184

3001

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.2

10.2

1612

13670

R53

ICD-10 Finland

Malaise and fatigue

1.1

10.2

3278

29387

NG1AA, ,

SPAT

1.2

10.1

1044

8475

H91.1

ICD-10 Finland

Presbycusis

1.3

10.1

638

4869

-1, ,

NOMESCO Finland

0.9

10.1

3715

40954

A12BA01

ATC

potassium chloride; oral

0.6

10.1

137

2404

QCE99, ,

SPAT

2.9

10.1

160

A11

ICPC

Chest pain NOS

1.2

10.1

1071

8728

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

0.3

10.0

866

N05AC02

ATC

thioridazine; oral

0.4

10.0

1308

A10AB04

ATC

insulin lispro; parenteral

0.6

10.0

132

2333

QAE99, ,

SPAT

1.9

10.0

124

663

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.3

9.9

781

A41.9

ICD-10 Finland

Sepsis, unspecified

0.6

9.9

150

2555

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.3

9.9

818

6473

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

9.9

1054

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.3

9.8

708

5503

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.7

9.8

501

6699

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.0

9.8

105

534

QX3HE, ,

SPAT

1.5

9.8

284

1896

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

0.5

9.8

1490

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.3

9.8

765

6012

SPAT1131

SPAT

Colonoscopy

0.6

9.8

146

2495

R23

ICD-10 Finland

Other skin changes

1.8

9.7

148

843

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.3

9.7

667

5155

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.4

9.7

373

2632

Z37.0

ICD-10 Finland

Single live birth

1.3

9.7

730

5712

SPAT1216

SPAT

Assessment of functional ability

0.8

9.6

1272

15183

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.4

9.6

408

2927

K05.31

ICD-10 Finland

Periodontitis pronounced

0.8

9.6

980

12009

C09AA02

ATC

enalapril; systemic

0.8

9.6

1645

19181

K58

ICD-10 Finland

Irritable bowel syndrome

1.5

9.6

309

2108

J01FA09

ATC

clarithromycin; systemic

1.1

9.6

4301

39346

N04AA02

ATC

biperiden; systemic

0.4

9.6

1312

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.4

9.6

507

3773

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.4

9.6

386

2747

ZXH09, ,

SPAT

1.5

9.6

265

1753

SFB40

NOMESCO Finland

Filling of four surfaces reproduced outside mouth

2.1

9.5

418

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.4

9.5

453

3316

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

1.8

9.4

137

769

D06BB03

ATC

aciclovir; topical

1.3

9.4

538

4048

U07

ICPC

Urine symptom/complaint other

1.2

9.4

1057

8664

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.1

9.4

6700

62854

U02

ICPC

Urinary frequency/urgency

1.2

9.4

1964

17050

SPAT1305

SPAT

Counselling and guidance related to physical exercise

0.8

9.4

689

8768

L19

ICPC

Muscle symptom/complaint NOS

1.4

9.4

344

2406

H58.8*A69.2

ICD-10 Finland

Ophthalmopathy in Lyme disease

+∞

9.4

A66.0

ICD-10 Finland

Initial lesions of yaws

+∞

9.4

AN1

Coronary angiography

0.8

9.4

726

9178

Z3226

NOMESCO Finland

Physiotherapist

1.2

9.4

2225

19508

H36.01

ICD-10 Finland

Diabetic maculopathy

0.3

9.4

816

Z25.1

ICD-10 Finland

Need for immunization against influenza

0.7

9.3

368

5124

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

9.3

1270

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

9.3

2403

21196

NH3EA

NOMESCO Finland

Feet X-ray examination with load

0.5

9.3

1611

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

1.7

9.3

179

1087

S01

ICPC

Pain/tenderness of skin

1.3

9.3

556

4214

L50

ICD-10 Finland

Urticaria

1.6

9.3

202

1265

S83

ICD-10 Finland

Dislocation, sprain and strain of joints and ligaments of knee

1.5

9.3

244

1596

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

0.7

9.3

485

6460

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

9.2

2021

17607

C09BA02

ATC

enalapril and diuretics; systemic

0.8

9.2

519

6843

N01

ICPC

Headache

1.2

9.2

1370

11549

N05AB03

ATC

perphenazine; systemic, rectal

0.6

9.2

168

2730

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

0.6

9.2

188

2976

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.3

9.2

848

6801

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

0.6

9.2

136

2329

H00.00

ICD-10 Finland

Hordeolum

1.3

9.1

548

4155

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

9.1

2468

21840

A91

ICPC

Abnormal result investigation NOS

1.3

9.1

634

4906

A11CC03

ATC

alfacalcidol; systemic

0.5

9.1

1651

DAX08

NOMESCO Finland

Fitting of hearing aid

1.3

9.1

617

4761

A10AA01, ,

ATC

0.5

9.1

1782

A26.0

ICD-10 Finland

Cutaneous erysipeloid

8.3

9.0

WX402

NOMESCO Finland

General anaesthesia

0.9

9.0

2487

27965

R053, ,

ICD-10 Finland

1.4

9.0

422

3082

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

0.5

9.0

1604

A10BK01

ATC

dapagliflozin; oral

0.8

9.0

622

7973

R01BA01

ATC

phenylpropanolamine; oral

1.3

9.0

608

4691

R12

ICD-10 Finland

Heartburn

1.2

9.0

1073

8856

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.5

8.9

1786

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.4

8.9

442

3256

188

Kela drug reimbursment

Psychosis requiring demanding treatment

0.2

8.9

618

L20

ICPC

Joint symptom/complaint NOS

1.4

8.9

472

3513

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

1.2

8.9

1164

9690

B03XA02

ATC

darbepoetin alfa; parenteral

0.5

8.9

1439

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

0.3

8.9

794

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.2

8.9

2376

21005

F20.10

ICD-10 Finland

Raise schizophrenia continuously

0.0

8.9

256

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.3

8.9

630

4890

S97

ICPC

Chronic ulcer skin

0.7

8.9

411

5576

A12AA04

ATC

calcium carbonate; oral

0.4

8.9

972

ZXE20

NOMESCO Finland

More than three and less than five hours

0.8

8.8

1112

13332

A10AD05

ATC

insulin aspart; parenteral

0.3

8.8

850

C07AB07

ATC

bisoprolol; oral

0.9

8.8

5751

61483

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

0.7

8.8

397

5404

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

0.4

8.8

1224

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.2

8.7

1371

11614

G04BD12

ATC

mirabegron; oral

1.2

8.7

1474

12569

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.3

8.7

829

SPAT1059

SPAT

Spirometry at the office

0.7

8.7

310

4385

R03DC03

ATC

montelukast; oral

1.2

8.6

2155

18958

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

1.5

8.6

228

1496

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

0.4

8.6

1115

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

2.0

8.5

477

DHB50

NOMESCO Finland

Turbinoplasty

1.5

8.5

283

1944

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

1.4

8.5

318

2233

NA3BG, ,

SPAT

1.3

8.5

495

3738

M54.5

ICD-10 Finland

Low back pain

1.1

8.5

5209

48415

N05AX12

ATC

aripiprazole; systemic

0.7

8.5

210

3187

SPAT1281

SPAT

Other administrative function

0.8

8.5

559

7211

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

1.5

8.5

268

1824

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

1.7

8.5

141

825

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.6

8.4

150

2451

A84.9

ICD-10 Finland

Tick-borne viral encephalitis, unspecified

7.3

8.4

R07.0

ICD-10 Finland

Pain in throat

1.2

8.4

882

7179

R03AC03

ATC

terbutaline; inhalant

1.2

8.4

1691

14632

C09CA06

ATC

candesartan; oral

1.1

8.4

3273

29658

N06DX01

ATC

memantine; oral

0.7

8.4

348

4801

S80.0

ICD-10 Finland

Contusion of knee

1.2

8.4

941

7716

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.3

8.3

815

6581

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.6

8.3

189

2920

F20

ICD-10 Finland

Schizophrenia

0.2

8.3

380

EBA05, ,

SPAT

1.6

8.3

187

1182

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

0.5

8.3

1264

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

0.4

8.3

911

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.1

8.3

4562

42160

T89

ICPC

Diabetes insulin dependent

0.7

8.2

217

3250

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

0.7

8.2

234

3452

M01AG02

ATC

tolfenamic acid; oral, rectal

1.2

8.2

1878

16410

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.6

8.2

137

2273

C08CA01

ATC

amlodipine; oral

0.9

8.2

4390

47469

M54.2

ICD-10 Finland

Cervicalgia

1.2

8.2

997

8245

DM1QA, ,

SPAT

1.3

8.2

481

3640

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.5

8.2

241

1618

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

1.5

8.2

254

1724

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.3

8.2

575

4462

L03

ICD-10 Finland

Cellulitis

1.8

8.1

124

708

H66.9

ICD-10 Finland

Otitis media, unspecified

1.3

8.1

732

5856

AN2

Balloon angioplasty, including several vessels

0.6

8.1

100

1798

WX872

NOMESCO Finland

Intensive care

0.7

8.1

308

4312

HAMTE, ,

NOMESCO Finland

0.2

8.1

529

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

8.1

2075

18286

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

1.6

8.1

172

1073

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

0.5

8.1

1295

S83.2

ICD-10 Finland

Tear of meniscus, current

1.2

8.1

828

6722

R06AE09

ATC

levocetirizine; oral

1.2

8.1

1793

15632

L60.9

ICD-10 Finland

Nail disorder, unspecified

1.6

8.1

199

1285

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

0.6

8.1

116

1999

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.2

8.1

896

7340

H3601, E113,

ICD-10 Finland

0.3

8.0

795

L89

ICD-10 Finland

Decubitus ulcer and pressure area

0.4

8.0

1154

Z75.2

ICD-10 Finland

Other waiting period for investigation and treatment

1.8

8.0

104

566

L50.9

ICD-10 Finland

Urticaria, unspecified

1.3

8.0

443

3323

SPAT1104

SPAT

Monitoring of emergency patient

0.7

8.0

432

5724

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.8

8.0

497

6458

K80

ICPC

Cardiac arrhythmia NOS

1.2

8.0

1067

8905

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

0.7

8.0

245

3561

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

1.6

8.0

162

1000

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

0.6

8.0

125

2104

PE1AT

NOMESCO Finland

Femoral artery PTA

0.3

8.0

700

R05

ICPC

Cough

1.1

8.0

3461

31553

C07AB02

ATC

metoprolol; systemic

0.9

8.0

1708

19567

C01DA14

ATC

isosorbide mononitrate; oral

0.8

7.9

1016

12164

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.5

7.9

1353

ZXC60

NOMESCO Finland

Application of heat

1.6

7.9

172

1079

L50.0

ICD-10 Finland

Allergic urticaria

1.4

7.9

298

2098

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

0.6

7.9

109

1896

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.4

7.9

330

2368

J01DC02

ATC

cefuroxime; systemic

1.3

7.9

618

4864

TNG10

NOMESCO Finland

Puncture of knee

1.7

7.8

135

798

KE1BG

NOMESCO Finland

MRI of prostate

1.9

7.8

520

RF210, ,

NOMESCO Finland

0.6

7.8

127

2119

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.3

7.8

708

5674

D07AC01

ATC

betamethasone; topical

1.1

7.8

5028

46821

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.2

7.8

1162

9804

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.5

7.8

212

1402

B35

ICD-10 Finland

Dermatophytosis

1.9

7.7

494

-1, ,

ICPC

0.7

7.7

205

3064

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

0.7

7.7

197

2968

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

0.5

7.7

1538

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.4

7.7

336

2428

I49.1

ICD-10 Finland

Atrial premature depolarization

1.3

7.7

433

3258

TUPAE, ,

NOMESCO Finland

3.9

7.7

D82

ICPC

Teeth/gum disease

1.1

7.7

5279

49300

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.6

7.7

167

2599

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

1.9

7.6

468

N02AA01

ATC

morphine; systemic, rectal

0.4

7.6

1090

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.2

7.6

858

7038

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

1.8

7.6

117

670

WX730

NOMESCO Finland

Conventional respirator

0.4

7.6

1034

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.3

7.6

629

4982

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

0.8

7.6

815

9932

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.2

7.6

934

7730

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

7.6

261

3716

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.3

7.6

456

3463

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.2

7.6

1032

8628

N05BA02

ATC

chlordiazepoxide; systemic

0.6

7.6

1646

ND1AA, ,

SPAT

1.4

7.6

330

2385

B01AA03

ATC

warfarin; systemic

0.9

7.6

1408

16312

R1100, ,

SPAT

0.4

7.5

1001

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.3

7.5

410

3069

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.3

7.5

510

3938

C01AA05

ATC

digoxin; systemic

0.7

7.5

360

4855

N02CC03

ATC

zolmitriptan; nasal, oral

1.3

7.5

613

4847

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.1

7.5

2173

19305

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.4

7.5

346

2523

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

0.2

7.5

395

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

0.2

7.5

567

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.2

7.5

843

6915

NHQ40

NOMESCO Finland

Amputation of toe

0.4

7.5

928

UJD10, ,

SPAT

1.4

7.5

304

2170

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.2

7.5

1156

9782

N05AF05

ATC

zuclopenthixol; systemic

0.3

7.5

613

R19.4

ICD-10 Finland

Change in bowel habit

1.4

7.4

339

2468

R95

ICPC

Chron obstructive pulmonary disease

0.6

7.4

141

2264

XX1XN

NOMESCO Finland

Other isotope examination

0.2

7.4

563

R49.03

ICD-10 Finland

Atrophic dysphonia

1.7

7.4

126

743

U09

ICD-10 Finland

Post COVID-19 condition

1.8

7.4

102

566

F10.20

ICD-10 Finland

Alcohol dependence currently independent

0.5

7.4

1400

WX290, ,

SPAT

1.4

7.4

377

2795

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

0.4

7.4

821

160

Kela drug reimbursment

exenatide

0.5

7.4

1451

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.2

7.4

814

6665

M20.2

ICD-10 Finland

Hallux rigidus

1.4

7.4

361

2660

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.2

7.4

1008

8434

WW500

NOMESCO Finland

Blood transfusion

0.7

7.4

224

3258

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

1.6

7.4

149

920

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

0.6

7.3

104

1795

UJH02

NOMESCO Finland

Anoscopy

1.3

7.3

459

3508

N05AH04

ATC

quetiapine; oral

0.9

7.3

1688

19241

SPAT1311

SPAT

Counselling and guidance related to occupational health

1.4

7.3

334

2433

NB2AT, ,

SPAT

1.8

7.3

525

K59.1

ICD-10 Finland

Functional diarrhoea

1.3

7.3

654

5231

DFF59

NOMESCO Finland

Other assessment of balance

1.7

7.3

113

649

C07FB02

ATC

metoprolol and felodipine; systemic

0.6

7.3

116

1944

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.4

7.3

340

2485

177

Kela drug reimbursment

Insulin glargine 300 U / ml

0.5

7.3

1365

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.3

7.3

654

5235

127

Kela drug reimbursment

Transplant complication

0.5

7.3

1123

F51.0

ICD-10 Finland

Nonorganic insomnia

1.1

7.3

2169

19315

ND2AA, ,

SPAT

1.3

7.2

649

5194

S72.0

ICD-10 Finland

Fracture of neck of femur

0.6

7.2

148

2334

XA402

NOMESCO Finland

ENMG

1.4

7.2

275

1942

XF610

NOMESCO Finland

Measurement of pulsvariation

3.4

7.2

PD3AT

NOMESCO Finland

Pelvic artery PTA

0.2

7.2

331

KAY20, ,

NOMESCO Finland

1.6

7.2

139

848

R01AD05

ATC

budesonide; nasal

1.2

7.2

862

7119

WX320

NOMESCO Finland

Spinalanesthesy

1.1

7.2

3204

29232

K40

ICD-10 Finland

Inguinal hernia

1.5

7.2

221

1499

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

0.8

7.2

1089

12835

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.2

7.2

1323

11368

E03

ICD-10 Finland

Other hypothyroidism

1.2

7.2

725

5882

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

0.7

7.2

249

3534

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

0.8

7.2

650

8060

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

0.2

7.2

484

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.4

7.2

951

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

1.6

7.2

153

958

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

0.6

7.1

125

2044

R01AD59

ATC

mometasone, combinations; nasal

1.2

7.1

775

6337

EB4VA, ,

NOMESCO Finland

1.1

7.1

2303

20611

H57.1

ICD-10 Finland

Ocular pain

1.3

7.1

451

3453

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.4

7.1

357

2643

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

0.2

7.1

384

XQ800

NOMESCO Finland

Prick test

1.2

7.1

859

7105

WVA20, ,

SPAT

0.7

7.1

214

3114

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.2

7.0

1305

11218

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

0.2

7.0

361

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

0.6

7.0

1544

SPD00

NOMESCO Finland

Mucosa borne complete denture

0.3

7.0

683

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

0.2

7.0

527

OAB48, ,

SPAT

1.1

7.0

2018

17922

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

0.4

7.0

801

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.2

7.0

815

6712

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.2

7.0

1032

8697

H81.3

ICD-10 Finland

Other peripheral vertigo

1.4

7.0

311

2257

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.3

7.0

636

J01MA02

ATC

ciprofloxacin; systemic

1.1

7.0

5151

48214

RTGOM, ,

NOMESCO Finland

3.1

7.0

O35.1

ICD-10 Finland

Maternal care for (suspected) chromosomal abnormality in fetus

1.5

7.0

181

1185

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.2

7.0

339

R03BB04

ATC

tiotropium bromide; inhalant

0.8

7.0

753

9165

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

0.5

7.0

1280

N07BA03

ATC

varenicline; oral

0.7

7.0

330

4451

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

0.7

6.9

178

2674

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

0.2

6.9

321

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

0.4

6.9

723

J33.8

ICD-10 Finland

Other polyp of sinus

1.5

6.9

220

1503

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

1.7

6.9

108

623

NH1BG, ,

SPAT

1.5

6.9

187

1236

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

0.5

6.9

1262

WZC30

NOMESCO Finland

Teaching

0.9

6.9

1708

19371

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

0.3

6.9

553

F16

ICPC

Eyelid symptom/complaint

1.3

6.9

613

4903

M25.9

ICD-10 Finland

Joint disorder, unspecified

1.7

6.9

116

684

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

0.6

6.9

126

2036

E87.5

ICD-10 Finland

Hyperkalaemia

0.5

6.9

1140

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.3

6.9

438

3359

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

1.4

6.8

244

1704

G03DC05

ATC

[U] tibolone

1.3

6.8

491

3826

EB1CA, ,

SPAT

1.8

6.8

552

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

1.5

6.8

210

1426

H3603, E103,

ICD-10 Finland

0.3

6.8

596

G50.1

ICD-10 Finland

Atypical facial pain

1.5

6.8

200

1345

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

0.7

6.8

162

2470

L29

ICD-10 Finland

Pruritus

1.6

6.8

166

1073

DM1AI, ,

SPAT

1.8

6.8

473

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.2

6.8

1305

11251

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.3

6.8

446

3435

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

6.7

124

2002

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.2

6.7

898

7497

R56.8

ICD-10 Finland

Other and unspecified convulsions

0.7

6.7

300

4085

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.2

6.7

1684

14811

U01

ICPC

Dysuria/painful urination

1.2

6.7

957

8038

A03FA01

ATC

metoclopramide; systemic, rectal

0.9

6.7

2413

26723

H40.1

ICD-10 Finland

Primary open-angle glaucoma

2.5

6.7

161

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.4

6.7

229

1586

E0000UV, ,

ATC

1.1

6.7

5855

55201

H25.8

ICD-10 Finland

Other senile cataract

1.2

6.7

1119

9536

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.5

6.7

216

1481

N05CD07

ATC

temazepam; oral

0.8

6.7

861

10297

C02EA02, ,

ATC

0.7

6.7

165

2496

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

1.6

6.7

132

812

WYA20

NOMESCO Finland

Home visit

0.5

6.7

1006

TK810

NOMESCO Finland

Hemofiltration

0.2

6.7

368

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

6.6

427

3278

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

1.3

6.6

422

3235

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

1.6

6.6

159

1024

T82

ICPC

Obesity

0.7

6.6

298

4050

OAB72

NOMESCO Finland

Weight control and weight loss guidance

0.3

6.6

617

N05AA01

ATC

chlorpromazine; systemic, rectal

0.4

6.6

808

J01FA06

ATC

roxithromycin; oral

1.1

6.6

5338

50147

E86

ICD-10 Finland

Volume depletion

0.6

6.6

1541

K05.1

ICD-10 Finland

Chronic gingivitis

1.2

6.6

798

6600

B35.4

ICD-10 Finland

Tinea corporis

1.6

6.6

154

986

KAY40, ,

NOMESCO Finland

1.5

6.6

208

1420

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

0.9

6.6

3247

35328

H3603, E113,

ICD-10 Finland

0.2

6.6

457

S15

ICPC

Foreign body in skin

1.2

6.6

766

6311

H00.1

ICD-10 Finland

Chalazion

1.3

6.6

440

3397

E66.8

ICD-10 Finland

Other obesity

0.8

6.6

421

5441

R52.0

ICD-10 Finland

Acute pain

1.3

6.6

355

2659

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.3

6.6

564

4494

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.1

6.6

2195

19684

H25

ICD-10 Finland

Senile cataract

1.7

6.6

114

678

Z10.0

ICD-10 Finland

Occupational health examination

1.2

6.6

1047

8888

SPA30

NOMESCO Finland

Grinding of a single crown and bridge pillar or a single post and crown

1.6

6.6

149

948

L02

ICPC

Back symptom/complaint

1.2

6.5

1294

11182

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.3

6.5

421

3233

M19.8

ICD-10 Finland

Other specified arthrosis

1.3

6.5

470

3663

SFA20

NOMESCO Finland

Two-surface restoration

1.1

6.5

8764

84116

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

0.4

6.5

702

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

0.5

6.5

1291

XX2RW, ,

NOMESCO Finland

0.5

6.5

1079

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.2

6.5

804

6663

N07BB01

ATC

disulfiram; oral

0.7

6.5

253

3519

E66.9

ICD-10 Finland

Obesity, unspecified

0.7

6.5

217

3098

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.2

6.5

939

7901

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

0.4

6.5

758

Z04

ICD-10 Finland

Examination and observation for other reasons

1.5

6.5

169

1109

G03DA04

ATC

progesterone; systemic, rectal, vaginal

1.3

6.5

373

2820

XQ855, ,

SPAT

0.4

6.5

884

NH1AA, ,

SPAT

1.3

6.5

360

2709

V03AE01

ATC

polystyrene sulfonate; oral

0.4

6.5

742

NB1DG, ,

SPAT

1.6

6.4

129

796

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

0.2

6.4

467

WX702

NOMESCO Finland

Supraglottic ventilation device

0.8

6.4

434

5572

Z50.0

ICD-10 Finland

Cardiac rehabilitation

0.3

6.4

577

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

6.4

11076

107398

J02

ICD-10 Finland

Acute pharyngitis

1.3

6.4

368

2784

G01AA10

ATC

clindamycin; vaginal

1.1

6.4

1796

15929

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

1.3

6.3

538

4281

A10BJ02

ATC

liraglutide; parenteral

0.7

6.3

171

2540

R4120

NOMESCO Finland

Occupational therapy

1.2

6.3

743

6130

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.6

6.3

1495

D06BX02

ATC

ingenol mebutate; topical

1.7

6.3

114

686

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

0.5

6.3

1302

A10AD01

ATC

insulin (human); parenteral

0.4

6.3

874

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

0.7

6.3

146

2235

N76.0

ICD-10 Finland

Acute vaginitis

1.2

6.3

678

5544

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

0.5

6.3

1326

64199

ICD-8 Finland

Abortion induced for other legal indications, Without mention of sepsis or toxaemia

0.8

6.3

455

5786

1048X

ICD-9 Finland

Other spirochaetal infection, Other specified spirochaetal infections[INFECTIO SPIROCHAETALES ALIA DEFINITA]

+∞

6.2

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.3

6.2

365

2768

P70

ICPC

Dementia

0.5

6.2

1232

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.3

6.2

468

3671

I84

ICD-10 Finland

Hemorrhoids

1.4

6.2

276

2006

N64.4

ICD-10 Finland

Mastodynia

1.3

6.2

380

2900

SPAT1255

SPAT

Intravenous administration of medicine

0.8

6.2

476

6011

E66.00

ICD-10 Finland

Metabolic syndrome

0.8

6.2

420

5384

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.5

6.2

1268

L71

ICD-10 Finland

Rosacea

1.4

6.2

299

2204

D11

ICPC

Diarrhoea

1.2

6.2

1467

12860

SPAT1053

SPAT

Memory test

0.8

6.1

1045

12195

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

6.1

1502

13190

SPAT1240

SPAT

Therapeutic discussion

0.8

6.1

848

10073

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.3

6.1

401

3090

C09CA01

ATC

losartan; oral

0.9

6.1

2795

30542

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

2.2

6.1

226

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

0.7

6.1

202

2884

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

0.4

6.1

634

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

0.6

6.1

130

2024

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.2

6.1

1119

9618

R41.3

ICD-10 Finland

Other amnesia

1.4

6.1

287

2108

R51.81

ICD-10 Finland

Facial pain NOS

1.4

6.1

262

1896

ITSEH, ,

NOMESCO Finland

0.2

6.0

294

H53

ICD-10 Finland

Visual disturbances

1.7

6.0

102

603

XFE00

NOMESCO Finland

Epicardial ultrasonography

0.6

6.0

1438

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

0.3

6.0

602

M01AC06

ATC

meloxicam; systemic, rectal

1.1

6.0

4948

46477

XQ899

NOMESCO Finland

Other assessment of skin

2.1

6.0

260

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

0.2

6.0

272

K07.60

ICD-10 Finland

Snapping jaw

1.2

6.0

580

4687

M02.8

ICD-10 Finland

Other reactive arthropathies

2.1

6.0

267

D07AB02

ATC

hydrocortisone butyrate; topical

1.1

6.0

3881

36060

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

414

467

9.06

307.65

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4417

10536

5.30

307.65

3.2

2.3

29.11

18.90

au/ml

13.68

971

981

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3967

9812

4.96

307.65

1.7

1.2

62.66

43.75

au/ml

8.34

787

413

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

419

545

7.86

301.58

1.1

986.20

307.72

ng/l

1.16

126

140

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

406

632

6.56

248.03

1.1

0.11

0.99

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3111

18685

1.81

175.35

5.1

5.0

32.97

32.36

2.12

1812

12740

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

548

1613

3.48

153.09

1.1

31.99

4.70

au/ml

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

225

358

6.36

134.46

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

482

1437

3.42

131.90

1.1

—

(40761536) Microorganisms panel - Urine sediment

464

12858

0.34

119.78

4.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

861

4063

2.18

94.82

1.2

1.4

569.15

530.66

mg/l

1.37

837

3880

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

799

15919

0.48

90.91

2.5

3.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

581

12976

0.43

89.91

2.7

3.9

1.23

mmol/l

1.23

517

11219

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

15546

146062

1.71

85.36

13.7

15.7

82.69

81.92

ml/min/173m2

6.17

14206

135373

(3019225) pH of Specimen

2255

14861

1.60

83.78

3.6

4.3

7.37

7.36

0.58

1377

10781

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

755

3590

2.15

81.38

1.2

1.3

3.52

3.76

mmol/l

11.11

711

3404

(3000963) Hemoglobin [Mass/volume] in Blood

16887

163836

3.40

78.16

22.2

24.8

136.40

135.28

g/l

25.61

16708

162400

(3007461) Platelets [#/volume] in Blood

16879

163748

3.32

77.46

22.0

24.7

248.62

254.24

e9/l

28.52

16514

160686

(3026361) Erythrocytes [#/volume] in Blood

16882

163808

3.34

77.17

22.0

24.6

4.52

4.49

e12/l

9.46

16426

160250

(3035941) MCH [Entitic mass]

16880

163789

3.32

76.93

21.9

24.5

30.39

30.31

9.50

16699

162328

(3024731) MCV [Entitic mean volume] in Red Blood Cells

16880

163794

3.31

76.83

22.0

24.6

91.19

91.07

3.29

16697

162335

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

16880

163802

3.31

76.66

22.4

25.1

41.00

40.87

0.18

16695

162286

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

113

158

7.19

76.33

1.0

1.1

—

(3010813) Leukocytes [#/volume] in Blood

16880

163828

3.30

76.13

22.0

24.7

6.36

6.69

e9/l

52.46

16464

160221

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16522

159324

2.08

66.76

12.3

12.6

25.68

26.37

u/l

5.87

15999

155275

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

333

1238

2.72

62.00

1.2

53.61

39.78

mg/l

2.99

317

1029

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

310

1112

2.82

61.80

1.1

—

(3017181) Myelocytes/Leukocytes in Blood

878

15145

0.56

61.23

4.3

4.5

0.88

0.95

0.26

292

4536

(3023410) Appearance of Cerebral spinal fluid

390

1592

2.48

60.02

1.3

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

322

1207

2.70

59.01

1.1

318.99

255.71

mg/l

4.16

308

1057

(3021440) Promyelocytes/Leukocytes in Blood

847

14500

0.56

57.22

4.3

4.6

0.09

0.12

0.47

263

3907

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15923

152492

1.64

56.97

6.0

5.9

2.79

2.74

mmol/l

11.52

14722

142994

(3002179) Metamyelocytes/Leukocytes in Blood

849

14456

0.57

56.17

4.2

4.4

0.70

0.72

0.10

309

4323

(3025159) Blasts/Leukocytes in Blood

866

14658

0.57

56.05

4.5

4.8

0.05

0.36

4.60

252

3735

(3010421) pH of Blood

160

5177

0.30

54.71

3.0

3.6

7.41

0.08

160

5117

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15680

149820

1.56

54.27

5.3

5.1

1.53

1.48

mmol/l

49.26

14490

140218

(3020564) Creatinine [Moles/volume] in Serum or Plasma

16527

160137

1.95

54.14

18.3

20.8

74.05

75.81

umol/l

20.42

16292

158568

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4817

39115

1.32

54.10

2.2

2.4

—

(3047181) Lactate [Moles/volume] in Blood

142

4859

0.29

53.88

3.3

5.9

1.23

1.30

mmol/l

0.62

131

4296

(3041096) Erythrocytes [Presence] in Urine by Automated

3626

45580

0.74

53.14

2.7

3.4

0.93

0.24

estimate

0.71

691

14159

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

15739

150633

1.56

52.64

5.2

4.76

4.68

mmol/l

20.54

14617

141766

(3029937) Albumin [Presence] in Urine by Test strip

3738

46724

0.74

52.57

3.8

4.2

0.00

estimate

4.59

838

16454

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

313

7218

0.42

51.34

3.2

5.1

1.47

1.63

2.42

302

6834

(3007930) Methemoglobin/Hemoglobin.total in Blood

268

6574

0.40

51.08

3.5

5.4

0.84

0.88

0.68

260

6209

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2484

32892

0.71

50.22

1.5

1.7

28571871.47

32863076.26

pmol/l

0.16

2051

27548

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

309

1241

2.52

49.28

1.2

1.3

1.92

2.14

mmol/l

3.46

281

1159

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3556

27967

1.34

48.91

2.9

3.0

0.83

1.23

e6/l

2.86

1812

14797

(3011397) Hemoglobin [Presence] in Urine by Test strip

4691

38551

1.30

46.76

3.5

3.8

0.29

0.31

—

360

(3008152) Bicarbonate [Moles/volume] in Arterial blood

530

9815

0.53

46.43

6.6

7.2

24.72

24.59

mmol/l

0.51

521

9398

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

237

861

2.78

46.23

1.1

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

12549

116400

1.29

45.41

4.7

4.5

10.09

11.97

mm/h

60.14

11686

109474

(3033658) Prothrombin time (PT) actual/Normal

4923

40873

1.29

44.96

3.6

4.2

92.41

91.11

3.53

4820

39954

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3194

24999

1.34

44.83

3.5

3.2

0.72

0.76

ug/l

1.42

2049

16330

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14998

142936

1.40

43.63

4.4

1.22

1.30

mmol/l

39.19

13679

132551

(3035320) C reactive protein [Mass/volume] in Body fluid

289

1214

2.40

41.88

3.0

2.7

24.87

27.83

mg/l

0.72

207

880

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2351

17750

1.38

41.28

5.1

6.7

—

(3027315) Oxygen [Partial pressure] in Blood

3338

0.25

41.05

3.4

3.9

8.82

8.70

kpa

0.31

3269

(3018572) Chloride [Moles/volume] in Blood

3349

0.26

40.61

3.9

7.0

104.93

105.10

mmol/l

0.19

3012

(3039000) Anion gap in Blood by calculation

3348

0.26

40.59

3.9

7.0

11.25

11.19

mmol/l

0.07

3010

(3013290) Carbon dioxide [Partial pressure] in Blood

3315

0.25

40.57

3.4

3.9

5.03

5.00

kpa

0.15

3247

(3012501) Base excess in Blood by calculation

3313

0.25

40.53

3.3

3.9

1.92

2.48

mmol/l

2.17

2262

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

384

1841

2.11

40.48

1.8

2.1

20.56

25.70

mg/l

1.16

722

(40768443) Skin Pathology biopsy report

1131

7469

1.55

40.15

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

15005

143396

1.38

39.52

5.9

6.4

37.85

39.16

mmol/mol

103.16

13801

135009

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

209

774

2.72

39.36

1.2

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

635

3641

1.77

39.20

1.3

1.5

254.86

2609.96

e6/l

1.56

461

2870

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15658

150812

1.45

38.78

14.1

16.2

22.41

23.66

mg/l

4.64

12444

124354

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3570

28888

1.30

38.67

1.4

1.3

11.57

11.80

u/ml

0.06

1180

11407

(3014051) Protein [Presence] in Urine by Test strip

5335

45490

1.25

37.32

2.8

2.9

0.00

0.07

8.28

983

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2233

17043

1.36

36.21

2.0

3.36

3.47

ratio

3.56

1739

13142

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3798

31253

1.28

35.59

1.4

1.3

34.24

33.28

iu/ml

0.11

1055

9594

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5522

63543

0.81

35.57

3.3

3.9

2.18

0.45

estimate

0.78

697

14491

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

615

3593

1.74

35.56

1.3

1.4

36.54

39.25

e6/l

0.09

424

2646

(3006462) Nitrate [Presence] in Urine

180

651

2.78

35.52

4.1

3.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

706

4286

1.68

35.45

1.2

3.92

3.82

0.10

591

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7812

69661

1.22

35.24

2.2

2.1

100.92

97.19

pmol/l

8.36

3755

36839

(1616796) Gas panel - Central venous blood

120

3591

0.33

35.17

3.1

3.8

—

(3037522) Nuclear Ab [Titer] in Serum

2958

23773

1.30

33.05

1.4

482.09

525.27

titre

0.67

632

5112

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3133

25481

1.28

31.73

3.0

3.1

2.33

2.87

e6/l

2.00

1379

12265

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14837

142344

1.32

31.58

5.7

5.6

1.89

mu/l

0.22

13534

132767

(4211845) Urine protein measurement

184

716

2.59

31.50

4.0

3.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3932

32968

1.25

30.65

1.5

2.31

2.41

g/l

2.34

2136

20497

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

186

4.26

30.56

1.2

1.3

78.51

50.99

6.09

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

192

777

2.49

30.31

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

756

4853

1.58

30.29

1.3

3.31

8.09

u/ml

5.36

720

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

756

4859

1.58

30.13

1.3

2.16

5.90

u/ml

2.00

474

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1673

12581

1.37

29.46

1.7

3.49

mmol/l

0.03

1169

8634

(3003327) Ova and parasites identified in Stool by Light microscopy

879

5898

1.52

28.85

1.8

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

393

2153

1.84

28.28

1.4

1.3

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

5.59

28.24

1.1

1.2

7.33

26.05

1.79

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15149

146127

1.32

28.18

5.3

5.2

5.75

5.92

mmol/l

84.81

13802

135490

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

791

5226

1.54

27.89

1.3

38.72

39.89

u/ml

0.03

284

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

311

1586

1.98

27.81

1.2

—

(3018010) Neutrophils/Leukocytes in Blood

8319

75655

1.19

27.62

6.7

55.64

57.09

26.61

7790

72459

(3035715) Granulocytes [#/volume] in Blood

110

3035

0.36

27.28

3.7

3.4

3.74

4.05

e9/l

1.21

110

3030

(36660697) Celiac disease serology panel - Serum

1742

13344

1.34

27.07

1.2

—

(3026782) Osmolality of Urine

2448

30080

0.78

26.40

2.5

3.0

548.55

526.87

mosm/kgh2o

5.16

2027

26448

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

116

395

2.95

25.71

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

640

4112

1.58

25.55

1.2

1.3

1.16

4.23

u/ml

2.92

271

(3023420) DNA double strand Ab [Units/volume] in Serum

1005

7096

1.44

25.48

1.7

1.8

8.43

7.17

iu/ml

0.50

203

1716

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

114

390

2.94

25.07

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

658

4280

1.56

24.90

1.3

14.26

14.23

u/ml

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

178

763

2.35

24.85

1.4

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

325

1763

1.86

24.20

1.2

30.94

46.24

u/ml

0.35

100

(3020682) Albumin/Creatinine [Ratio] in Urine

4684

53329

0.83

23.86

3.7

4.2

6.13

8.40

mg/mmol

1.51

2589

32682

(3037467) Urinalysis macro (dipstick) panel - Urine

11314

106380

1.19

23.58

4.5

4.6

1.68

2.39

0.90

163

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1964

15579

1.29

23.56

2.3

2.6

37.23

49.45

u/l

1.36

1667

13232

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

110

385

2.87

23.25

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

2623

21590

1.25

23.21

2.3

2.4

110.69

133.22

ug/g

2.98

2005

17219

(3027273) Bicarbonate [Moles/volume] in Venous blood

427

6936

0.61

22.83

2.6

3.5

25.30

25.29

mmol/l

0.05

421

6713

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

259

1331

1.96

22.74

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

15812

154065

1.35

22.66

15.9

18.9

3.95

3.96

mmol/l

7.54

15428

151086

(3013650) Neutrophils [#/volume] in Blood by Automated count

9826

91446

1.18

22.62

9.1

10.2

3.73

4.09

e9/l

44.10

8303

79527

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

264

1369

1.94

22.58

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

5780

51525

1.18

22.51

2.2

2.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

453

2760

1.66

22.51

1.1

18.03

14.32

au/ml

0.35

106

669

(3019550) Sodium [Moles/volume] in Serum or Plasma

15782

153746

1.34

22.50

15.7

18.7

139.92

139.71

mmol/l

24.65

15436

151009

(3006315) Basophils [#/volume] in Blood

8895

82155

1.17

22.40

6.7

6.6

0.04

e9/l

1.65

7452

70794

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8041

73690

1.17

22.27

2.4

2.5

79.28

1294.78

nmol/l

0.50

7081

67366

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

402

2380

1.71

22.26

1.2

2.59

12.82

u/ml

3.14

103

(3013115) Eosinophils [#/volume] in Blood

9135

84600

1.17

22.09

6.8

0.19

e9/l

3.13

7818

74094

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

262

1367

1.93

22.02

1.2

—

(3001604) Monocytes [#/volume] in Blood

8867

81937

1.17

22.01

6.7

6.6

0.55

0.58

e9/l

40.17

7435

70627

(3006504) Eosinophils/Leukocytes in Blood

8187

75195

1.17

21.89

6.8

2.92

2.85

2.25

7588

70684

(3019069) Monocytes/Leukocytes in Blood

8205

75390

1.17

21.79

6.9

8.83

8.79

0.69

7612

70933

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11263

106155

1.18

21.67

3.3

3.4

40.72

47.88

u/l

19.19

10528

100126

(40759836) Histone Ab [Presence] in Serum by Immunoblot

264

1389

1.91

21.65

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

267

1419

1.90

21.25

1.2

—

(3000012) Reticulocyte production index

2228

0.34

21.21

2.2

2.1

0.94

0.92

0.14

1489

(3018333) Ribosomal P Ab [Presence] in Serum

247

1286

1.93

20.92

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

251

1317

1.92

20.77

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

9019

83673

1.16

20.65

6.7

6.6

1.93

e9/l

0.03

7745

73831

(3022096) Basophils/Leukocytes in Blood

8167

75197

1.16

20.64

6.9

0.73

0.69

8.76

7565

70645

(3022806) Fractional oxyhemoglobin in Capillary blood

1861

0.29

20.59

1.8

91.18

89.91

0.89

1834

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

790

5565

1.44

20.27

2.6

2.5

0.73

0.80

g/l

0.24

689

4803

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

360

2.79

20.13

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1473

18650

0.77

19.58

7.0

8.0

13.51

12.55

kpa

7.60

1436

17994

(3003396) Base excess in Arterial blood by calculation

1460

18503

0.77

19.55

7.0

8.0

0.49

0.94

mmol/l

5.62

1286

15402

(3022145) Colonoscopy Study observation

2320

19173

1.24

19.51

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

199

3.43

19.48

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1475

18657

0.77

19.45

7.0

8.1

5.09

5.10

kpa

0.13

1436

18008

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2103

0.35

19.38

2.3

2.1

33.33

32.63

1.01

2088

(3019977) pH of Arterial blood

1476

18656

0.77

19.35

7.0

8.1

7.43

7.42

3.00

591

10151

(3002030) Lymphocytes/Leukocytes in Blood

8336

77106

1.16

19.24

6.7

6.8

29.53

28.07

30.47

7841

73251

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

265

4656

0.56

19.20

1.4

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

199

991

2.02

19.19

1.1

0.85

1.18

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

667

4600

1.47

19.14

1.5

23.97

16.25

iu/ml

0.44

103

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

888

12024

0.72

18.85

2.2

2.9

136.51

174.30

ng/l

4.70

802

10991

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1207

15595

0.76

18.64

7.9

8.9

122.69

121.08

g/l

2.31

1199

15237

(3016502) Oxygen saturation in Arterial blood

1301

16615

0.77

18.41

7.4

8.4

95.87

95.69

0.40

1285

16059

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4739

42095

1.17

18.32

6.1

5.5

2.30

3.04

ug/l

3.30

4245

38336

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

376

2306

1.64

18.29

1.1

3.70

2.44

0.50

377

(3022621) pH of Urine by Test strip

1586

12635

1.28

18.17

2.4

2.6

6.00

6.06

2.02

877

8444

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

288

1662

1.75

17.59

1.2

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

264

1489

1.79

17.45

1.2

79.30

79.96

u/ml

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

612

4232

1.46

17.35

2.7

2.5

0.00

g/l

-0.00

568

3966

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1522

12132

1.28

17.33

2.3

13.73

13.01

nmol/l

2.81

1360

10984

(1761482) Bacteria [#/volume] in Urine by Culture

182

3451

0.52

17.14

4.0

4.1

—

(3000034) Microalbumin [Mass/volume] in Urine

1378

0.26

16.90

3.3

3.0

77.75

49.11

mg/l

0.20

989

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

775

5622

1.40

16.87

1.6

1.7

3.20

4.37

mg/l

3.03

557

4202

(3012516) Albumin [Mass/volume] in Urine

4712

52509

0.86

16.84

3.3

3.5

34.64

46.04

mg/l

1.80

2672

32879

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1761

21444

0.80

16.68

4.4

6.2

1.02

1.04

mmol/l

2.23

1603

20060

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3831

33665

1.18

16.60

4.5

21.71

21.88

0.28

1834

16374

(3005988) Vibrio sp identified in Specimen by Organism specific culture

323

1958

1.66

16.49

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

107

4.12

16.47

1.3

1.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

13204

127013

1.17

16.35

18.7

20.6

332.49

332.20

g/l

3.62

13155

126412

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

183

3.29

16.18

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1120

14353

0.76

16.18

5.2

7.9

8.02

9.56

mmol/l

14.99

1068

13784

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

563

3887

1.46

16.11

1.2

1.3

44.64

44.99

u/ml

0.01

366

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4015

35490

1.17

16.10

1.7

1.8

1.03

1.18

mg/l

1.80

2987

27603

(3025468) Yersinia sp identified in Specimen by Organism specific culture

320

1948

1.65

16.08

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

321

1956

1.65

16.07

1.4

—

(3032080) INR in Blood by Coagulation assay

6624

71854

0.87

15.96

12.9

13.9

1.22

inr

0.00

4988

59831

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7325

67678

1.14

15.94

1.8

1.9

1.27

1.37

mmol/l

26.12

6157

56936

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

684

9399

0.72

15.86

8.6

10.2

16.24

16.03

1.32

677

9074

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7745

71896

1.14

15.57

5.5

6.8

1.22

1.21

mmol/l

18.44

7028

66840

(3006184) Hemoglobin [Mass/volume] in Capillary blood

224

3887

0.57

15.57

1.7

2.3

131.19

129.68

g/l

0.35

116

2964

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

849

6333

1.36

15.57

1.6

12.98

17.28

u/ml

1.28

160

1464

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

638

4539

1.42

15.55

2.7

2.4

0.00

g/l

1.12

569

3976

(3031040) Bacteria [#/volume] in Urine by Automated count

10722

101715

1.15

15.53

4.5

4.7

5102.92

1644.25

e6/l

0.68

1363

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

598

4221

1.43

15.23

1.1

1.2

—

(3023368) Bacteria identified in Blood by Culture

3785

42620

0.86

15.11

3.7

4.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

658

4732

1.41

15.09

2.7

2.4

0.01

0.02

g/l

0.47

595

4259

(3009508) Creatinine [Moles/volume] in Urine

5105

56210

0.87

14.97

3.2

3.5

7.64

7.49

mmol/l

1.51

4147

47799

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

819

6116

1.36

14.92

2.6

2.4

2.82

2.88

g/l

1.13

734

5587

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12539

120399

1.16

14.84

8.0

8.6

75.39

79.02

u/l

15.86

11799

114818

(40758558) Short blood count panel - Blood

5367

48722

1.15

14.77

6.7

6.6

—

(3002256) Pathology report gross observation

2541

21747

1.20

14.74

1.3

—

(3021589) Normoblasts [#/volume] in Blood

6586

71215

0.88

14.62

9.1

11.8

0.00

e9/l

3.77

4959

58244

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

185

3.14

14.58

1.1

—

(44806420) Estimation of glomerular filtration rate

1857

0.41

14.52

2.1

2.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

328

2064

1.60

14.47

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

598

4266

1.42

14.38

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

596

4256

1.41

14.25

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1012

7864

1.30

14.00

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

161

835

1.94

13.97

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1900

15915

1.22

13.76

2.2

2.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

330

2106

1.58

13.75

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

324

2063

1.58

13.63

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4989

54729

0.88

13.43

3.0

3.4

31.38

34.02

u/l

3.17

4700

51699

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

259

1569

1.66

13.35

1.3

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

1794

0.43

13.14

1.6

10.1

6.92

7.53

mmol/l

0.73

1511

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4222

37946

1.15

13.07

1.3

1.68

1.71

u/ml

0.03

870

10457

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

843

6464

1.32

12.86

2.5

2.4

4.17

4.25

g/l

1.56

759

5939

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

843

6471

1.32

12.76

2.5

2.4

7.06

7.39

g/l

7.02

757

5939

(1002224) Polysomnography panel

992

7787

1.29

12.72

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

142

732

1.95

12.60

1.1

5.63

7.52

u/ml

0.47

123

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

160

859

1.87

12.56

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

170

933

1.83

12.45

1.5

6.09

8.12

ug/l

2.48

163

846

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

838

6452

1.31

12.42

2.5

2.4

3.56

3.70

g/l

1.94

752

5925

(3021960) Folate [Moles/volume] in Serum or Plasma

4930

44912

1.14

12.35

1.6

1.7

21.64

20.29

nmol/l

8.69

3953

38308

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

441

6255

0.70

12.34

1.9

2.0

1.49

2.13

ug/l

1.02

394

5621

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

319

2.45

12.34

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

214

3531

0.60

12.32

2.2

2.4

100.22

107.84

ug/min

0.10

119

2126

(1761868) Lipid panel - Serum or Plasma

5660

61352

0.88

12.31

2.7

3.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

358

5274

0.67

12.30

1.5

1.8

—

32.21

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

193

1107

1.75

12.20

1.1

25.64

19.12

u/ml

0.85

447

(3045414) Leukocytes [Presence] in Urine

1854

15705

1.20

11.88

2.2

2.1

0.00

0.02

estimate

6.85

210

3282

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

575

7743

0.73

11.74

2.9

4.1

50.77

48.17

1.86

568

7635

(3026493) Urate [Moles/volume] in Serum or Plasma

4651

42341

1.14

11.63

2.5

2.7

328.02

337.52

umol/l

10.06

4034

37539

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

161

892

1.81

11.48

1.1

1.23

1.10

u/l

0.78

361

(3038026) Centromere Ab [Units/volume] in Serum

212

1276

1.67

11.29

1.3

1.2

35.81

54.27

u/ml

0.70

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1917

0.49

11.25

1.5

57.99

59.71

ug/l

0.14

1917

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1719

14546

1.20

11.12

2.1

2.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

396

2758

1.45

10.96

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

163

2.95

10.94

1.1

—

(3012544) pH of Venous blood

1341

16113

0.82

10.92

3.0

4.1

7.38

1.18

628

9219

(3051387) C reactive protein [Mass/volume] in Capillary blood

191

3141

0.60

10.90

3.3

3.5

31.23

26.22

mg/l

0.59

2163

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

400

2796

1.44

10.86

1.5

1.17

1.15

ratio

0.18

231

1697

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

400

2804

1.44

10.71

1.5

1.17

1.21

ratio

0.45

234

1717

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

400

2804

1.44

10.71

1.5

0.98

0.95

ratio

0.74

231

1706

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

122

633

1.93

10.70

2.0

2.1

40.84

40.23

g/l

0.45

122

633

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

718

5528

1.31

10.68

2.5

2.4

9.98

10.11

g/l

0.37

624

4946

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1242

0.38

10.63

1.3

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1322

15858

0.82

10.57

2.9

4.1

5.81

5.82

kpa

0.18

1295

15479

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

144

2520

0.57

10.48

1.4

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1534

12918

1.21

10.43

2.8

2.9

10.41

10.50

g/l

0.37

1439

11976

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1031

8336

1.25

10.38

1.1

16.98

7.80

u/ml

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2428

27580

0.86

10.27

2.8

3.6

0.83

0.82

mmol/l

9.95

2248

26055

(3004775) Volume in Urine collected for unspecified duration

1170

0.38

10.10

2.7

2.3

631.20

663.46

0.27

824

(3033099) Centromere Ab [Titer] in Serum

415

2.13

10.06

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

357

5063

0.70

10.05

2.6

3.3

0.36

0.35

iu/ml

0.10

177

2800

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12595

121934

1.12

10.02

4.5

4.6

14.62

14.75

pmol/l

8.33

11410

112818

(3002032) Base excess in Venous blood by calculation

1293

15452

0.82

9.93

2.9

4.1

1.60

1.83

mmol/l

1.76

1174

13619

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

12331

127179

0.89

9.90

17.4

19.8

13.42

13.61

65.84

12211

125609

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

686

5307

1.30

9.88

1.1

0.60

0.62

ratio

0.33

715

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

148

2529

0.58

9.88

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

771

9733

0.78

9.83

2.2

3.5

133.86

129.27

g/l

8.33

752

9456

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1529

17967

0.84

9.78

1.7

1.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

545

4088

1.34

9.75

1.6

10413.99

13541.63

e6/l

1.42

384

2877

(3000494) Fungus identified in Specimen by Culture

2290

20079

1.16

9.64

1.4

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

198

1224

1.62

9.58

1.1

8.41

8.46

iu/ml

0.01

308

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

412

2967

1.40

9.52

1.6

1.5

67.08

60.19

ug/l

0.79

333

2444

(36304419) Bacteria [Presence] in Urine

4615

42414

1.12

9.47

3.2

0.35

274.41

estimate

0.86

164

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1028

8401

1.24

9.41

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

899

7238

1.26

9.41

2.0

42.30

39.61

u/l

3.55

793

6473

(4027681) Cerebrospinal fluid IgG ratio and IgG index

164

970

1.70

9.41

1.2

0.59

0.68

ratio

0.55

107

552

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

968

0.35

9.35

21.8

20.3

1306.76

2414.97

nmol/l

0.58

931

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

113

2044

0.55

9.31

1.5

—

(3008898) HLA-B27 [Presence]

707

5536

1.29

9.31

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1368

11533

1.20

9.19

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3072

27589

1.14

9.16

1.9

—

(3044889) 12 lead EKG panel

10472

108797

0.90

9.14

3.7

4.0

0.18

3425.02

1.18

223

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

276

1861

1.49

9.10

1.5

1.8

11226.67

1471.11

titre

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4779

51655

0.90

9.09

2.5

2.7

62.53

64.97

u/l

0.37

4323

47947

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

164

982

1.68

9.01

1.1

4.59

7.92

nmol/l

0.60

182

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

253

1684

1.51

8.89

1.6

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

161

2.74

8.82

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

925

0.36

8.81

1.4

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

360

2571

1.41

8.77

1.2

0.69

1.07

1.02

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

156

2.76

8.76

1.1

—

(40762814) Titanium [Mass/volume] in Blood

232

2.42

8.74

2.7

2.5

2.97

3.78

ug/l

1.17

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

964

0.37

8.71

1.4

1.5

—

(3041354) Potassium [Moles/volume] in Venous blood

1613

0.51

8.70

1.9

2.3

4.03

mmol/l

0.03

1597

(3035285) Chloride [Moles/volume] in Venous blood

1612

0.51

8.68

1.9

2.3

105.98

105.47

mmol/l

0.46

1596

(3019150) Specific gravity of Urine by Refractometry

3370

37071

0.89

8.63

3.6

4.1

1.02

1.14

kg/l

1.09

2075

24583

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

152

2.77

8.61

1.0

1.1

—

(3018095) Leukocytes [#/volume] in Urine

6287

59027

1.10

8.38

4.0

52.15

94.73

e6/l

10.91

3946

41436

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

668

5270

1.28

8.33

1.8

1.18

1.20

g/l

0.63

633

5043

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1109

9255

1.21

8.30

1.6

1.7

—

(4146454) Self-monitoring of blood glucose

247

1663

1.49

8.25

2.8

2.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

182

1147

1.59

8.21

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1581

0.52

8.19

1.9

2.3

1.20

mmol/l

0.31

1565

(3003434) Protein [Mass/volume] in Pleural fluid

123

2082

0.59

8.01

1.4

1.5

33.44

33.63

g/l

0.06

112

1902

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1026

0.42

7.99

1.3

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

647

5118

1.27

7.91

1.8

0.23

0.24

g/l

1.02

608

4878

(3000850) Epithelial cells [#/volume] in Urine

3246

35628

0.89

7.91

2.5

2.8

4.75

5.76

e6/l

3.58

2878

32497

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

515

0.19

7.82

1.1

3.5

11.92

10.40

kpa

—

515

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

514

0.19

7.80

1.1

3.5

4.65

4.97

kpa

—

514

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

375

5051

0.74

7.78

2.9

3.5

1.28

1.52

mg/l

10.23

348

4629

(3049717) Cytology report of Urine Cyto stain

692

5531

1.26

7.77

2.7

2.6

—

(37208534) Antinuclear antibody arbitrary concentration in serum

100

545

1.84

7.69

1.0

1.1

—

(4015189) Microbial culture of sputum

385

2.00

7.64

1.6

2.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

243

3502

0.69

7.59

3.1

2.8

31.99

34.04

umol/l

0.72

217

3171

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7915

75354

1.09

7.58

3.1

3.2

109.66

124.76

ug/l

7.36

7329

70622

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

589

4633

1.28

7.55

1.9

44.88

41.67

nmol/l

2.61

573

4509

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

193

2.44

7.53

1.1

—

(3004451) EKG impression Narrative

883

0.40

7.47

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

612

4846

1.27

7.45

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

303

2169

1.40

7.36

1.1

3.70

3.66

eliau/ml

0.01

119

1022

(3044242) Glucose [Moles/volume] in Arterial blood

863

0.39

7.36

1.5

2.1

7.36

8.09

mmol/l

0.78

863

(3006576) Bicarbonate [Moles/volume] in Blood

508

0.22

7.31

7.0

6.5

26.61

25.07

mmol/l

1.27

464

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

696

5610

1.25

7.29

3.1

4.0

24.93

24.87

mmol/l

0.30

645

5195

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

181

2737

0.66

7.27

1.6

—

(3005033) Fetal Nuchal fold Thickness US

315

2282

1.39

7.15

1.5

1.28

1.25

0.35

225

1642

(3047352) Trisomy 18 risk [Likelihood] in Fetus

320

2325

1.38

7.14

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

327

2388

1.38

7.08

1.6

—

(3042631) Mycobacterium sp identified in Specimen

129

2086

0.62

7.04

2.8

2.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

223

3212

0.69

6.98

1.4

—

(3023419) Bacteria identified in Sputum by Culture

134

2143

0.62

6.98

2.5

2.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1227

0.50

6.98

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

148

2312

0.64

6.95

4.8

6.5

10.81

11.84

mg/l

2.29

137

2145

(3025130) Human papilloma virus identified in Specimen

340

2507

1.36

6.94

1.7

1.8

—

(3017569) Oxygen content in Arterial blood

867

0.41

6.91

2.1

2.3

16.24

15.94

0.24

867

(3015736) pH of Urine

7105

67498

1.09

6.90

3.2

3.5

6.20

6.22

0.55

3443

37719

(3029075) Extractable nuclear Ab panel - Serum

164

1057

1.56

6.80

1.1

—

0.33

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1520

13265

1.16

6.76

1.7

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

226

1561

1.45

6.73

1.7

1.8

—

(40761535) Cells panel - Urine sediment

1333

11524

1.17

6.71

3.3

3.5

—

0.83

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

896

7485

1.21

6.68

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

228

3244

0.70

6.68

1.8

2.0

0.86

0.85

nmol/l

0.05

190

2757

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

130

2069

0.63

6.65

1.3

7.14

7.33

mmol/l

0.24

109

1832

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

254

3540

0.71

6.60

2.8

3.7

410.08

859.91

u/ml

0.65

226

3221

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

311

4191

0.74

6.54

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1136

13204

0.85

6.36

2.0

2.5

0.38

0.40

e6/l

0.17

1052

12609

(3002523) Influenza virus A Ag [Presence] in Specimen

375

2856

1.32

6.21

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

163

1073

1.52

6.19

2.4

2.7

0.69

e9/l

0.02

158

1018

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

643

5240

1.24

6.16

1.2

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

454

1.81

6.09

2.6

3.3

1.94

1.92

ratio

0.03

412

(21494755) Public health laboratory ask at order entry panel

1626

14369

1.15

6.08

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

329

4347

0.75

6.07

1.7

1.6

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

1477

0.58

6.04

1.5

1.6

35.65

31.57

0.52

868

(3009466) Valproate [Moles/volume] in Serum or Plasma

149

2249

0.66

6.01

4.7

5.5

365.73

364.52

umol/l

0.03

117

1974

(3003740) Influenza virus B Ag [Presence] in Specimen

373

2854

1.31

5.99

1.1

—

(40768797) Stomach Pathology biopsy report

2529

23012

1.12

5.88

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

366

1.89

5.87

1.1

1.2

—

836.36

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

749

0.43

5.80

4.0

4.1

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

420

0.24

5.80

1.3

1.4

1.50

2.48

—

364

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8353

80252

1.08

5.75

5.8

7.5

1.22

1.21

mmol/l

18.68

7407

69485

(3035880) pH of Pleural fluid

774

0.44

5.75

1.1

1.3

7.43

7.41

0.51

539

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

233

3208

0.72

5.69

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

140

2112

0.66

5.66

1.4

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

285

3798

0.75

5.62

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

564

4580

1.24

5.61

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

153

1017

1.51

5.60

1.3

156.73

175.91

pmol/l

0.86

153

1017

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

430

3385

1.28

5.59

2.0

1.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

564

4594

1.24

5.47

2.1

12.36

11.43

mg/l

1.40

523

4313

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

238

1734

1.38

5.34

1.4

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1423

0.60

5.28

1.3

269.99

412.31

u/l

2.84

1360

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

710

5944

1.20

5.25

1.3

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1452

12870

1.14

5.21

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2111

19142

1.12

5.21

2.7

2.8

7.04

8.45

umol/l

2.91

1874

16701

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

144

2.36

5.20

1.0

1.1

0.08

0.03

u/ml

0.52

144

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

431

3429

1.26

5.17

1.1

2.27

1.86

u/ml

0.32

233

1839

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

189

1332

1.42

5.16

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2359

25782

0.90

5.11

1.8

1.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2554

27786

0.90

5.05

2.3

2.7

14.29

13.19

umol/l

11.62

2410

25946

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

323

2486

1.31

5.04

1.2

3.26

3.84

u/ml

0.54

158

1151

(3030467) Casts [#/volume] in Urine by Automated count

4731

44626

1.08

5.04

3.3

0.29

0.40

e6/l

3.95

3156

32601

(3041806) Other cells [#/volume] in Blood by Manual count

393

1.78

5.04

1.5

0.56

0.51

e9/l

1.11

393

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1380

0.61

5.04

1.8

1.4

1.01

1.26

promille

0.86

1072

(3036071) Salmonella sp Ab [Titer] in Serum

482

1.70

5.03

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

654

5457

1.21

5.03

1.7

1.9

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

147

994

1.48

5.00

1.4

1.5

5.64

6.00

u/l

0.42

125

862

(3000919) Neutrophils/Leukocytes in Pleural fluid

377

0.26

4.90

1.3

1.4

34.58

21.71

—

342

(3045424) Erythrocytes [Presence] in Urine

936

8076

1.17

4.89

2.2

0.00

0.24

estimate

1.08

164

2598

(3023199) Leukocytes [#/volume] in Pleural fluid

123

1839

0.67

4.83

1.4

1.5

2934.40

3158.93

e6/l

0.06

1285

(3024354) Oxygen [Partial pressure] in Venous blood

1158

13149

0.87

4.77

2.4

3.5

4.57

4.56

kpa

0.06

1134

12804

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.27

4.74

1.0

1.1

0.04

u/ml

0.10

(3007853) Bacteria identified in Skin by Aerobe culture

1726

19107

0.89

4.73

1.6

1.8

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

819

7017

1.18

4.69

1.5

1.6

12.43

15.13

iu/ml

0.24

187

(3029634) Reagin Ab [Titer] in Serum by VDRL

287

2198

1.31

4.68

1.8

2.1

4.00

8.08

titre

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3388

31622

1.09

4.61

2.8

3.1

2.44

2.45

mmol/l

5.98

2990

28505

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

406

5034

0.80

4.60

2.4

2.2

5517.91

5063.67

u/l

0.12

154

1921

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

332

1.81

4.57

1.1

30.68

31.70

iu/ml

0.05

332

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

849

0.53

4.52

1.3

5.67

5.80

mmol/l

0.50

798

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1732

19111

0.90

4.47

1.7

1.8

—

(3020650) Glucose [Presence] in Urine

562

0.43

4.46

2.8

1.6

0.13

0.04

estimate

0.31

562

(3024891) Influenza virus A+B Ag [Presence] in Specimen

492

4046

1.22

4.43

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

269

2059

1.31

4.43

1.1

0.74

0.49

u/ml

0.27

685

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

264

3430

0.77

4.43

1.4

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5177

49206

1.07

4.41

2.1

2.2

154.85

202.25

u/l

8.89

4899

46536

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

162

2.16

4.41

1.3

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

370

2953

1.26

4.39

1.1

3.87

4.69

u/ml

0.69

201

1547

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

106

2.46

4.36

1.5

1.4

11.70

35.71

3.24

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

110

724

1.52

4.32

1.6

1.7

29.79

29.29

umol/l

0.21

104

683

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

205

2.00

4.24

1.0

1.1

0.29

0.18

u/ml

0.23

131

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

635

5380

1.19

4.19

1.5

0.32

8.81

iu/ml

1.22

119

1018

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

433

3537

1.23

4.19

1.9

204.47

199.37

pmol/l

0.50

407

3352

(40757373) Influenza virus identified in Isolate

286

0.31

4.18

1.1

1.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

293

2288

1.29

4.18

1.1

3.86

4.83

u/ml

0.50

125

1015

(3023487) Leukocytes [#/volume] in Peritoneal fluid

642

0.48

4.17

1.8

2.0

833.40

2978.15

e6/l

0.80

428

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

486

4020

1.22

4.16

1.2

—

(3042733) HLA Ab [Presence] in Serum

558

0.45

4.14

3.6

4.9

—

(3013727) Leukocytes other/Leukocytes in Blood

472

0.40

4.11

3.2

3.7

41.34

52.91

1.32

458

(3043410) Blood group antigens tested for on Red Blood Cells

399

0.35

4.11

1.5

1.8

—

(3010375) cycloSPORINE [Mass/volume] in Blood

728

0.52

4.06

27.2

29.7

116.06

114.94

ug/l

0.04

590

(3045683) HLA typing for celiac disease panel - Blood or Tissue

136

948

1.44

4.04

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

552

0.45

4.03

1.8

1.9

2681.62

13432.61

e6/l

1.62

277

(3022475) Manganese [Moles/volume] in Blood

2.45

4.03

1.0

1.3

0.17

0.16

umol/l

0.16

(3014133) Dog dander IgE Ab [Units/volume] in Serum

307

2425

1.27

4.01

1.1

3.68

4.03

u/ml

0.13

138

1195

(3042936) Bacteria identified in Isolate by Culture

2109

22910

0.91

4.01

1.7

2.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

157

1126

1.40

3.99

2.4

2.7

226.31

235.72

e6/l

0.28

137

963

(3045788) Cell count panel - Pleural fluid

100

1489

0.67

3.93

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1049

9284

1.14

3.91

2.2

2.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

144

2.15

3.91

2.1

2.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

359

0.33

3.91

1.1

—

39.21

u/ml

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1317

0.65

3.89

1.6

—

(3003129) Base excess in Capillary blood by calculation

247

1909

1.30

3.85

2.0

2.3

0.62

0.58

mmol/l

0.07

241

1843

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2398

25845

0.92

3.83

2.2

2.6

2.37

2.35

g/l

1.18

2221

23950

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

601

1.53

3.79

2.0

1.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

112

1619

0.69

3.78

1.4

1.5

36031.73

56421.67

e6/l

0.88

892

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

338

1.72

3.77

1.2

339.28

323.24

pmol/l

0.06

250

(3003181) Sodium [Moles/volume] in Urine

230

2972

0.77

3.76

1.4

59.22

62.72

mmol/l

0.72

181

2374

(3013005) Retinol [Moles/volume] in Serum or Plasma

110

749

1.47

3.73

1.6

1.8

2.01

1.96

umol/l

0.27

691

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

117

1672

0.70

3.72

1.0

1.2

—

33.88

—

(3051101) Glucose [Moles/volume] in Cord blood

236

0.30

3.70

3.0

6.1

6.97

8.42

mmol/l

—

236

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

447

1.61

3.70

1.6

1.7

0.34

0.39

ug/l

0.61

334

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

515

4339

1.19

3.67

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

213

1627

1.31

3.64

1.2

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

234

0.30

3.56

9.9

11.0

5.09

5.31

mmol/l

—

234

(21494434) Karyotype in Bone marrow

181

1360

1.33

3.49

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

350

2857

1.23

3.48

1.1

0.60

1.04

u/ml

2.10

156

1268

(3010726) Horse dander IgE Ab [Units/volume] in Serum

340

2767

1.23

3.48

1.1

1.40

1.62

u/ml

0.21

168

1412

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

688

5968

1.16

3.46

1.9

2.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

161

1191

1.36

3.45

1.4

10.49

12.54

umol/l

6.01

151

1122

(3052592) Norovirus Ag [Presence] in Stool

258

0.35

3.40

1.0

1.3

—

(40768806) Pleura Pathology biopsy report

110

1560

0.70

3.39

1.5

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

376

0.40

3.38

3.1

2.4

6.60

102.33

ug/l

0.68

376

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

103

708

1.46

3.37

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

103

708

1.46

3.37

1.4

—

(3024316) Viscosity of Plasma

2.50

3.37

1.1

1.8

1.51

1.58

mpas

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

231

1.82

3.36

1.6

2.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

427

0.44

3.28

5.9

7.5

6.15

5.96

kpa

0.51

383

(3005011) Chlamydia sp Ab [Titer] in Serum

212

1.84

3.24

1.7

1.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

109

764

1.43

3.23

1.1

3.83

3.77

iu/ml

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2221

23840

0.92

3.22

2.3

2.7

24.03

22.62

5.56

2097

22190

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1392

0.70

3.21

1.3

9.74

8.75

mmol/l

1.16

1313

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

148

1982

0.74

3.21

1.0

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

441

1.57

3.19

1.4

1.3

17.48

16.72

umol/l

0.66

382

(3039162) Centromere protein B Ab [Units/volume] in Serum

272

2185

1.25

3.17

1.2

1.3

76.97

62.15

u/ml

—

139

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

123

1689

0.73

3.15

1.4

1.3

1.38

1.49

nmol/l

0.39

102

1522

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

863

7660

1.13

3.14

2.1

1.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

224

2831

0.79

3.14

1.8

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

177

1350

1.31

3.12

1.1

296.86

291.14

mg/l

0.41

159

1225

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

147

1091

1.35

3.12

2.2

2.5

460.69

526.04

e6/l

1.21

124

879

(3015377) Calcium [Moles/volume] in Serum or Plasma

5786

55693

1.06

3.11

3.3

3.6

2.37

2.36

mmol/l

7.98

5012

50883

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

199

2545

0.78

3.08

1.1

78.98

5219.91

iu/ml

0.66

533

(3010144) Erythrocytes [#/volume] in Synovial fluid

192

1484

1.30

3.08

1.4

42407.72

129891.84

e6/l

2.74

127

989

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1462

15940

0.91

3.03

2.4

2.3

378.66

376.53

nmol/l

0.15

1351

14820

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

177

0.28

2.95

1.6

1.2

5.24

5.96

mmol/l

—

177

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1167

0.68

2.93

1.6

1.9

1.00

1.80

u/field

1.45

644

(3018418) pH of Serum or Plasma

4668

48685

0.94

2.91

3.7

4.4

7.40

1.54

2986

34813

(3034988) Calcium [Moles/volume] in Capillary blood

278

0.36

2.89

6.6

2.0

1.17

1.18

mmol/l

—

263

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

402

0.47

2.84

1.1

1.3

53.09

40.46

0.60

269

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

667

1.43

2.84

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

797

0.63

2.82

1.3

1.9

162.85

129.41

umol/l

0.23

400

(3027923) C peptide [Moles/volume] in Serum or Plasma

942

0.66

2.81

1.8

1.5

1.27

1.24

nmol/l

0.06

721

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

121

888

1.37

2.80

1.1

1570.24

1541.62

miu/ml

0.10

121

888

(3002621) Streptococcal DNAse B [Units/volume] in Serum

151

1.92

2.78

1.0

1.1

169.80

370.85

u/ml

—

(3052851) Hemolysis interference index of Serum or Plasma

508

4388

1.16

2.78

2.7

3.2

3.24

2.30

index

0.45

238

2229

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

301

0.40

2.77

7.8

6.6

10.65

10.49

0.10

301

(3008116) Ketones [Moles/volume] in Urine by Test strip

362

1.58

2.76

1.2

1.5

0.27

0.31

mmol/l

0.10

(3005322) IgE [Units/volume] in Serum or Plasma

1214

11074

1.10

2.76

1.3

184.72

244.99

u/ml

1.44

1143

10292

(3044007) Cell count panel - Peritoneal fluid

540

0.55

2.73

1.8

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1354

12425

1.10

2.72

1.4

1.5

—

(3024471) HLA-A [Type]

526

0.55

2.71

1.0

—

(44790049) Parainfluenza type 3 nucleic acid detection

167

2142

0.78

2.70

1.4

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

167

2142

0.78

2.70

1.4

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

167

2142

0.78

2.70

1.4

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

167

2142

0.78

2.70

1.4

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

388

1.55

2.70

1.2

1.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

932

0.66

2.69

11.2

13.7

0.60

0.63

mmol/l

0.56

849

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

552

1.45

2.65

1.6

2.1

9.45

9.13

mg/l

0.19

461

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.33

2.64

1.0

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

304

3644

0.83

2.63

4.2

5.9

503.18

1458.98

iu/ml

1.16

543

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1259

11534

1.10

2.63

1.2

161.23

138.71

u/ml

1.01

429

4453

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

562

1.44

2.61

1.3

1.2

108.78

110.55

0.26

502

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

506

1.46

2.58

1.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

222

1792

1.24

2.56

1.1

98.94

96.81

0.64

204

1688

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

545

4765

1.15

2.56

2.5

179.24

193.12

3.73

513

4529

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

274

0.40

2.53

4.1

2.1

1.19

mmol/l

0.05

263

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

170

1333

1.28

2.51

1.1

1.2

183.93

201.88

titre

0.11

224

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

592

1.42

2.50

2.1

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

592

1.42

2.50

2.1

2.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

212

1708

1.24

2.50

1.7

1.8

306.53

358.37

mu/l

2.79

172

1346

(3038071) Oxygen [Partial pressure] in Mixed venous blood

382

0.50

2.50

5.9

7.3

5.04

5.45

kpa

0.83

382

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

225

1.69

2.45

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

404

3467

1.17

2.45

1.5

1.4

—

(3001556) Androgen free Index in Serum or Plasma

116

1.98

2.44

1.7

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

119

893

1.33

2.44

2.4

2.2

5.46

3.59

ug/l

0.93

109

831

(3048929) Epstein Barr virus Ab [Presence] in Serum

570

5019

1.14

2.43

1.2

1.3

—

(3000492) Spirometry study

1733

16158

1.08

2.43

1.5

—

20.46

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

181

1438

1.26

2.42

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

215

1742

1.24

2.42

3.7

3.5

54.62

57.25

1.06

191

1513

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

173

0.35

2.39

2.0

2.5

0.50

0.61

u/field

—

173

(3013826) Glucose [Moles/volume] in Serum or Plasma

9035

92320

0.95

2.39

4.2

5.2

6.40

6.67

mmol/l

43.03

8565

87670

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

480

5493

0.87

2.37

2.5

2.7

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

6.25

2.37

1.0

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

599

1.40

2.37

2.1

2.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

334

2832

1.18

2.36

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

120

907

1.33

2.35

1.1

—

(3024932) HLA-DR beta [Type]

515

0.58

2.35

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

306

1.57

2.34

1.0

1.1

1.04

1.79

u/ml

0.28

261

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

675

0.64

2.33

3.2

3.5

1.57

1.31

0.53

675

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

601

1.40

2.33

1.4

1.2

0.30

g/l

0.07

482

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

435

0.55

2.29

1.3

1.2

4.15

11.78

pmol/l

—

161

(3025577) Chromium [Mass/volume] in Blood

115

868

1.33

2.29

2.3

2.2

3.33

2.37

ug/l

0.94

723

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

961

10533

0.91

2.28

3.2

3.8

5.09

5.15

kpa

1.97

905

10097

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

288

0.45

2.27

2.8

2.9

11.56

40.50

mg/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

290

2440

1.19

2.25

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

113

1.95

2.24

1.0

1.2

0.49

0.67

iu/ml

0.41

(4195642) Thrombophilia screening test

280

2350

1.19

2.24

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

280

2351

1.19

2.23

1.1

121.83

117.60

1.35

248

2132

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

300

2535

1.19

2.22

1.2

3.03

3.38

u/ml

0.18

110

927

(3016244) Insulin [Units/volume] in Serum or Plasma

126

968

1.30

2.22

3.6

3.3

21.97

26.54

mu/l

0.98

117

918

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

515

1.42

2.21

1.2

1.1

90.67

88.73

0.16

237

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

474

1.44

2.19

1.1

1.3

149.03

129.33

nmol/l

0.57

348

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

110

831

1.33

2.19

1.3

4.19

4.43

umol/l

0.39

740

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

193

1566

1.24

2.18

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

389

0.54

2.18

1.1

1.4

29.18

25.17

g/l

0.55

299

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

517

1.41

2.17

1.1

1.0

5.73

10.94

u/ml

2.38

326

(3002719) Hemoglobin [Mass/volume] in Urine

3.69

2.15

1.0

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

151

0.33

2.13

1.6

1.4

11.30

16.75

pmol/l

—

127

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

145

1142

1.27

2.13

1.3

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

346

1.50

2.12

1.2

102.10

78.94

—

107

(3024980) IgG subclass 4 [Mass/volume] in Serum

342

2939

1.17

2.09

1.6

0.74

0.75

g/l

0.06

287

2273

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

143

1128

1.27

2.08

1.3

1.2

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.56

2.07

1.0

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.56

2.07

1.0

1.1

0.19

0.22

g/l

0.89

(3013336) Amino acids [Identifier] in Serum or Plasma

2.90

2.07

1.4

2.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1260

0.75

2.06

1.3

1.2

—

(21494815) CD4 cells/Lymphocytes in Specimen

171

1379

1.24

2.06

1.9

2.3

42.03

39.21

1.69

166

1351

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

414

1.45

2.06

1.4

1.7

49.58

137.15

au/ml

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

747

6761

1.11

2.06

1.3

0.41

1.08

u/ml

2.30

553

(4268621) Lupus anticoagulant assay

218

1805

1.21

2.05

2.3

—

(40768793) Breast Pathology biopsy report

479

4227

1.14

2.03

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

192

1.67

2.02

1.1

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

601

1.37

2.02

1.1

1.2

—

(3048879) Bone marrow aspiration report

392

1.46

2.00

2.1

2.0

—

2.00

—

(3022725) Serotonin [Moles/volume] in Serum

2.22

2.00

1.5

1.3

436.29

963.62

nmol/l

1.26

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.22

2.00

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

290

2471

1.18

1.99

1.4

28.75

31.38

u/l

0.61

230

2010

(3027456) Digoxin [Moles/volume] in Serum or Plasma

228

2722

0.84

1.98

3.6

3.2

0.73

0.81

nmol/l

2.72

176

2183

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

146

1163

1.26

1.98

1.1

—

0.57

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

344

1.48

1.98

1.2

62.88

72.27

—

101

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

230

2741

0.84

1.96

1.5

1.3

32.95

30.65

u/l

0.13

199

2369

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

196

2369

0.83

1.95

1.3

294.78

372.75

pmol/l

0.86

178

2022

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

130

1023

1.27

1.95

1.2

1.3

74.29

61.08

titre

—

(3005570) Glucose [Moles/volume] in Urine

122

1552

0.78

1.95

1.8

2.0

—

0.86

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

134

1.79

1.94

1.1

1.3

19.96

14.82

nmol/l

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.19

1.94

1.0

1.4

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

265

1.55

1.94

1.1

1.65

9.35

u/ml

1.41

175

(3014599) Egg white IgE Ab [Units/volume] in Serum

121

945

1.28

1.93

1.0

1.1

2.18

6.25

u/ml

0.46

236

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

504

1.39

1.93

1.1

1.2

1100.00

980.77

titre

0.38

104

(4038314) Semen analysis, post vasectomy

2.11

1.91

1.1

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

161

1980

0.81

1.91

1.9

2.5

1.07

1.22

g/24h

0.23

1180

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

164

2008

0.81

1.87

1.0

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

813

8881

0.91

1.86

3.0

3.6

1.39

1.79

mmol/l

3.27

612

6617

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

5815

56561

1.04

1.85

3.3

3.5

1.23

2.06

e6/l

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.98

1.84

1.1

1.0

2.06

0.27

u/ml

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

101

777

1.30

1.83

2.4

1.9

141.00

152.41

0.82

731

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

244

2869

0.85

1.81

2.6

2.8

529.62

3016.73

u/ml

1.03

150

(3026389) Candida sp identified in Specimen by Organism specific culture

214

2544

0.84

1.81

1.3

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

194

1613

1.21

1.79

3.8

3.7

—

(3024869) Neuronal Ab [Presence] in Serum

303

1.49

1.79

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

413

0.60

1.76

1.1

1.3

2.27

271.00

ug/l

2.54

224

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

1.86

1.75

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

102

1.86

1.75

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

144

1771

0.81

1.74

1.8

1.4

278.97

278.67

mosm/kgh2o

0.06

1350

(3023383) Lactate [Moles/volume] in Pleural fluid

436

0.62

1.74

1.2

1.3

2.99

3.47

mmol/l

0.61

400

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.50

1.73

1.0

1.1

2.67

3.08

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

472

4213

1.12

1.72

1.1

4.15

7.44

eliau/ml

1.26

524

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

131

1051

1.25

1.71

1.2

1.3

20.00

530.69

titre

—

(40768800) Prostate Pathology biopsy report

320

2787

1.15

1.70

1.3

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

508

1.36

1.70

1.4

1.1

89.23

90.44

0.07

240

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

1.70

0.0

8.4

—

(3009343) pH of Capillary blood

947

10227

0.92

1.69

3.2

3.8

7.42

4.34

739

8538

(3036670) Protein [Mass/volume] in Synovial fluid

483

1.37

1.69

1.3

38.41

39.81

g/l

0.29

253

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

1.68

0.0

2.2

—

4.40

—

(3044927) Protein electrophoresis panel - Urine

178

1479

1.21

1.68

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

105

824

1.28

1.66

1.1

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2503

23934

1.05

1.65

1.6

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

119

1.77

1.65

1.1

1.2

—

(4024509) Urine culture

805

7404

1.09

1.65

1.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

121

967

1.25

1.65

1.0

1.1

0.96

1.84

u/ml

0.60

316

(3015076) Soybean IgE Ab [Units/volume] in Serum

109

861

1.27

1.64

1.0

1.1

0.30

1.66

u/ml

1.05

214

(3022493) Free Hemoglobin [Mass/volume] in Plasma

679

0.71

1.64

3.0

4.9

4821.60

598.93

mg/l

0.42

489

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

354

0.59

1.63

1.2

1.3

1.20

1.18

mmol/l

0.64

354

(3014111) Lactate [Moles/volume] in Serum or Plasma

1526

14392

1.07

1.62

6.1

8.1

1.28

1.33

mmol/l

0.86

1484

14137

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

128

1.72

1.59

1.2

1.1

—

(3036489) Thrombin time

672

6143

1.10

1.59

1.9

2.1

20.49

21.07

1.93

593

5407

(40768446) Kidney Pathology biopsy report

685

0.71

1.57

1.3

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

144

1.67

1.57

1.0

1.1

2.07

1.66

iu/ml

0.56

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.82

1.56

1.2

1.5

350.83

306.79

umol/24h

0.57

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

235

0.51

1.56

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

833

0.74

1.55

1.5

1.7

3.97

7.28

nmol/l

0.41

685

(3037692) Legionella sp identified in Specimen by Organism specific culture

578

0.69

1.55

1.5

1.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.11

1.54

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

305

2670

1.14

1.54

1.2

—

(4198724) Urine methamphetamine measurement

659

0.71

1.54

1.6

2.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

768

8328

0.92

1.54

2.1

3.2

1.14

1.26

3.49

762

8288

(3017817) Protein [Mass] in Urine collected for unspecified duration

110

1370

0.80

1.54

1.9

2.6

763.66

1073.90

1.74

110

1358

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

159

0.44

1.53

1.1

1.2

—

0.45

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

1.52

0.0

1.3

—

132.75

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

747

1.27

1.51

1.2

10.05

10.25

mm/h

0.06

747

(3032352) Blasts [#/volume] in Cerebral spinal fluid

177

1.58

1.51

2.1

2.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

644

0.71

1.50

3.4

1.7

7889.40

359.32

pmol/l

0.46

106

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.86

1.50

1.1

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.07

1.49

1.0

1.1

4.99

0.52

u/ml

0.43

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

131

1.68

1.49

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

308

1.43

1.48

1.3

93.41

94.13

mu/l

0.00

231

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

256

0.55

1.48

1.7

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

218

1.51

1.48

1.1

—

(3011048) Pyruvate [Moles/volume] in Blood

1.81

1.46

1.6

1.2

69.53

80.89

umol/l

0.89

(3023511) Choriogonadotropin [Units/volume] in Urine

207

2415

0.86

1.46

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2322

24231

0.95

1.45

2.0

2.2

29.31

29.55

1.27

2281

23598

(3044009) aPTT.lupus sensitive (LA screen)

132

1.67

1.45

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

252

2190

1.15

1.44

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

2.73

1.43

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

376

0.64

1.41

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

130

1070

1.22

1.40

1.4

1.8

6.28

6.73

mmol/l

2.05

109

744

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1095

11663

0.93

1.40

1.6

1.7

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

139

0.43

1.38

1.5

1.3

21.23

21.12

mmol/l

—

107

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.77

1.38

1.1

1.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3130

30228

1.04

1.38

3.6

3.9

319.62

434.56

ng/l

1.12

2377

23039

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

784

1.25

1.38

4.1

6.2

11766.80

5489.08

u/ml

—

132

(3045142) Bone marrow Pathology biopsy report

213

1836

1.16

1.37

1.3

—

(3017509) Phencyclidine [Presence] in Urine

161

0.50

1.35

1.6

1.5

—

(3014891) Appearance of Pleural fluid

162

0.49

1.35

2.0

1.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

256

1.45

1.35

1.3

1.1

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

0.00

1.34

0.0

8.6

—

51.69

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

161

1364

1.18

1.30

1.1

—

(3006270) Folate [Moles/volume] in Blood

137

1144

1.20

1.30

1.2

1.1

384.42

366.40

nmol/l

0.47

128

984

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

569

1.28

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

464

1.32

1.28

2.0

2.2

0.18

0.50

e9/l

1.00

220

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

226

1.46

1.28

1.1

1.0

12.35

8.07

u/ml

0.25

226

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

131

0.46

1.28

1.0

1.1

—

18.30

—

(3011412) CD3 cells [#/volume] in Blood

182

1561

1.17

1.27

2.2

2.4

1204.30

1201.02

e6/l

0.02

161

1377

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

565

0.73

1.26

2.7

3.2

28.33

28.26

umol/l

0.01

426

(4212803) Bone marrow aspirate examination

130

1.62

1.26

1.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

356

3199

1.12

1.24

1.9

5.29

5.09

mmol/24h

0.57

310

2862

(3003694) ABO and Rh group [Type] in Blood

4393

45081

0.97

1.24

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

165

1408

1.17

1.23

1.2

122.49

109.20

pmol/l

1.04

165

1408

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

100

1.70

1.23

4.7

6.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

922

0.79

1.22

1.2

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1183

12503

0.94

1.22

2.1

2.3

7.79

7.64

ug/l

0.07

1005

11108

(3036603) Volume of Urine

150

1272

1.18

1.21

1.7

1.6

2040.13

1972.03

0.47

150

1240

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.63

1.21

1.2

1.0

4500.00

2913.68

titre

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.80

1.20

1.0

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

365

1.34

1.20

1.1

1.2

—

(4034850) Laboratory test

520

4777

1.09

1.18

7.8

9.9

—

(3011436) Histone Ab [Units/volume] in Serum

349

1.35

1.18

1.1

—

21.20

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.70

1.17

3.6

3.8

—

0.00

estimate

—

(40757494) Bilirubin.total [Moles/volume] in Blood

793

0.78

1.16

1.8

2.2

42.77

37.81

umol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

481

5243

0.92

1.16

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

5272

51572

1.03

1.16

3.3

3.4

61.84

75.69

e6/l

0.23

3723

39306

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

248

0.60

1.15

1.9

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

223

0.58

1.15

1.2

2.2

0.51

1.11

mmol/l

—

152

(3020630) Protein [Mass/volume] in Serum or Plasma

1403

13361

1.05

1.14

2.6

2.7

66.87

66.43

g/l

1.64

1263

12326

(3019174) dRVVT (LA screen)

134

1.57

1.14

1.2

—

(40768795) Lymph node Pathology biopsy report

149

1739

0.86

1.13

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

139

1181

1.18

1.12

1.1

1.2

77.80

81.97

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

120

1425

0.84

1.12

2.9

3.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

944

0.80

1.12

1.1

1.04

1.06

ratio

1.75

782

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

217

1.43

1.10

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

127

1073

1.18

1.10

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

302

1.36

1.10

1.8

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

171

1968

0.87

1.08

1.5

1.6

46.30

57.04

3.07

121

1208

(3011985) Renin [Units/volume] in Plasma

226

2552

0.88

1.08

1.5

64.94

63.15

mu/l

0.05

200

2289

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

556

5999

0.92

1.07

3.5

3.7

433.92

1736.67

u/ml

1.72

481

5179

(3017143) Hepatitis C virus Ab [Presence] in Serum

1921

18470

1.05

1.07

1.5

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

670

7177

0.93

1.07

1.7

1.35

1.56

g/l

8.69

564

6209

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

278

1.37

1.07

1.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

173

1505

1.15

1.05

3.7

3.8

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

279

1.36

1.05

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

279

1.36

1.05

1.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

203

2301

0.88

1.04

2.9

2.7

4.97

834.02

u/ml

1.29

203

2279

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

162

1.48

1.03

1.0

0.00

2.84

u/ml

0.55

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

297

1.35

1.03

1.8

1.4

15058.33

278744.52

u/ml

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.27

1.03

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.27

1.03

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.27

1.03

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.27

1.03

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.27

1.03

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.27

1.03

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.83

1.02

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

987

0.82

1.02

1.2

1.1

16.38

23.69

u/l

2.04

879

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

365

3330

1.10

1.01

1.2

1.4

9.01

25.51

u/ml

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.88

1.00

1.2

1.1

28.09

62.57

umol/24h

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

995

0.82

0.99

1.2

1.1

76.86

82.65

u/l

0.46

883

(3020961) Endomysium IgA Ab [Titer] in Serum

832

7844

1.06

0.99

1.1

148.24

207.38

titre

0.52

223

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.17

0.98

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.17

0.98

1.0

2.79

0.53

u/ml

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

158

0.57

0.98

1.1

—

(3000330) Specific gravity of Urine by Test strip

813

7664

1.06

0.98

2.9

3.3

1.02

ratio

2.29

701

6912

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

320

2907

1.10

0.97

3.4

3.8

31.05

35.87

u/ml

0.24

310

2814

(3033086) Enterovirus Ab [Titer] in Serum

1.80

0.96

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

199

0.60

0.96

1.3

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

190

1.42

0.96

1.4

1.3

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.96

0.0

1.5

—

437.55

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1373

13142

1.05

0.95

2.8

2.7

72.31

67.41

ml/min/173m2

5.74

525

5494

(3028433) Virus identified in Specimen by Culture

505

1.25

0.95

1.2

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.00

0.95

0.0

1.6

—

1714.25

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

791

0.81

0.94

1.1

1.3

94.08

63.80

6.67

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

613

5734

1.07

0.94

1.8

2.3

170.94

586.24

ug/l

10.09

563

5432

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

242

1.36

0.94

1.8

2.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.89

0.94

1.0

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

524

1.24

0.94

1.1

1.3

3.90

26.38

5.75

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

824

1.19

0.94

2.0

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

824

1.19

0.94

2.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

824

1.19

0.94

2.0

1.9

—

(40758292) HTLV I+II Ab panel - Serum

312

1.31

0.92

1.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

197

1749

1.13

0.92

1.1

0.89

1.98

iu/ml

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

7076

71816

0.97

0.92

4.2

5.2

36.92

35.83

g/l

62.85

6620

67594

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

826

1.19

0.92

2.0

1.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

238

2645

0.90

0.91

1.5

1.6

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

159

1.45

0.90

1.0

0.01

0.46

u/ml

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.60

0.90

1.1

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

102

1.57

0.90

1.1

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

111

1296

0.86

0.90

2.1

2.3

19.09

18.10

nmol/l

0.57

106

1223

(21494890) Protein electrophoresis panel - 24 hour Urine

143

1638

0.87

0.90

2.0

2.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

474

1.25

0.89

1.1

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

646

1.21

0.89

1.7

1.4

37.95

34.18

nmol/l

0.46

576

(3035350) Ketones [Presence] in Urine by Test strip

8374

84781

0.98

0.88

3.5

3.9

10.34

3.33

estimate

0.98

886

18065

(21491868) Cryoglobulin [Mass/volume] in Serum

601

1.22

0.88

1.2

0.09

0.22

g/l

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

111

950

1.17

0.88

2.1

2.2

100.36

98.18

0.30

103

888

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

556

1.22

0.88

3.5

3.7

8.64

8.65

mg/l

0.00

447

(3025941) Bacteria identified in Stool by Culture

924

8780

1.06

0.87

1.2

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

170

1502

1.13

0.87

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

103

1.55

0.87

1.3

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

555

5192

1.07

0.87

1.4

283.71

275.14

ug/g

0.45

300

3021

(3019309) Folate [Moles/volume] in Red Blood Cells

2454

25270

0.97

0.87

1.6

1.7

1047.04

1163.30

nmol/l

8.30

1695

19339

(3034274) Bile acid [Moles/volume] in Serum --fasting

191

1702

1.12

0.86

2.1

5.34

8.42

umol/l

3.02

138

1245

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

504

1.23

0.85

2.5

2.7

38.84

145.29

au/ml

—

(3017732) Neutrophils [#/volume] in Blood

2155

20884

1.04

0.85

3.0

3.2

4.25

4.42

e9/l

0.41

1618

18248

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

364

3355

1.09

0.84

1.2

1.4

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.94

0.84

1.0

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5782

58769

0.98

0.83

3.3

3.7

33.57

63.32

ng/l

2.30

3783

39877

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

129

1.47

0.83

1.4

1.6

0.69

1.62

mg/l

1.45

(3004809) Band form neutrophils/Leukocytes in Blood

245

2701

0.91

0.83

3.7

3.5

1.69

1.58

0.15

222

2450

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

240

1.33

0.82

2.5

1.7

—

(3014271) Vancomycin [Susceptibility]

616

1.20

0.82

2.5

2.9

—

(3042517) Benzodiazepines panel - Urine

177

0.62

0.81

1.2

2.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

203

1825

1.11

0.80

1.4

6.41

6.79

g/l

0.96

167

1309

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

575

0.80

0.79

1.4

14.59

15.33

pmol/l

0.53

475

(3024928) Oxygen saturation in Venous blood

431

4015

1.08

0.78

1.9

3.5

60.54

62.00

0.70

422

3885

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

148

1.42

0.77

1.0

0.10

0.60

u/ml

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

198

0.66

0.76

1.2

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

202

1823

1.11

0.75

1.4

0.35

0.41

g/l

2.05

167

1306

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

714

0.83

0.75

1.9

2.1

24.94

136.78

ug/min

2.28

161

(3035637) Corticotropin [Mass/volume] in Plasma

203

2245

0.90

0.75

1.5

24.64

29.78

ng/l

1.75

203

2238

(3016038) Potassium [Moles/volume] in Urine

1069

0.86

0.74

1.2

41.04

34.49

mmol/l

1.41

937

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

546

5141

1.06

0.74

2.1

2.3

94.48

93.17

0.80

527

4950

(4133840) Spirometry

403

0.77

0.74

1.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

629

5952

1.06

0.73

1.3

1.4

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

491

0.79

0.72

1.1

1.6

—

173.63

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

237

1.31

0.72

1.0

78.20

78.86

ug/l

0.03

187

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.55

0.71

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1870

19261

0.97

0.70

1.6

1.8

1.38

1.45

5.43

1639

16840

(3028192) IgG subclass 2 [Mass/volume] in Serum

201

1824

1.10

0.69

1.4

2.85

2.91

g/l

0.24

167

1310

(3024263) Appearance of Synovial fluid

786

1.16

0.69

1.6

1.7

—

(4035726) Immunohistochemistry procedure

1507

14578

1.04

0.69

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

319

1.25

0.68

1.5

1.9

3.70

3.04

ug/l

0.15

188

(40765089) Chromosome analysis panel - Blood by G-banded

392

1.23

0.67

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

468

4404

1.06

0.67

1.4

10.78

11.11

u/l

0.19

370

3510

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

106

1207

0.88

0.67

1.7

1.8

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.63

0.66

1.1

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

265

2872

0.92

0.66

1.3

—

14.60

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

540

1.19

0.65

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

139

1552

0.89

0.64

1.2

1.3

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

1.72

0.64

1.0

0.03

0.05

u/ml

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

438

4648

0.94

0.62

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

120

1067

1.13

0.62

1.2

1.3

16.75

23.19

u/l

1.87

882

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

351

1.23

0.62

1.2

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

101

0.59

0.62

1.7

1.2

27.00

1044.14

u/l

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

653

6847

0.95

0.61

1.7

0.28

0.31

mg/l

0.81

278

3251

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

107

1208

0.89

0.61

1.9

2.1

—

(4062490) Immunoglobulin typing, IgG

196

1792

1.09

0.61

1.4

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.60

0.0

1.2

—

0.53

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.4

—

97.47

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.60

0.0

2.7

—

(3026726) Creatinine [Moles/volume] in Specimen

140

0.64

0.60

1.3

2.6

527.22

391.75

umol/l

—

134

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.60

0.0

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

863

8287

1.04

0.60

1.4

30.97

29.83

iu/l

0.44

736

7081

(3020717) Zinc [Moles/volume] in Serum or Plasma

111

986

1.13

0.59

1.4

1.5

29.86

23.45

umol/l

1.11

100

914

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.54

0.59

1.1

1.3

1.30

1.37

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

333

0.78

0.59

6.5

4.7

58.31

57.19

u/l

0.02

326

(3028026) IgM [Mass/volume] in Serum or Plasma

1058

10208

1.04

0.58

1.8

1.9

1.36

1.30

g/l

0.41

964

9431

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

114

1.40

0.58

1.0

1.1

0.02

0.21

u/ml

1.83

114

(3045177) Copper [Moles/volume] in Urine

0.00

0.58

0.0

1.1

—

0.56

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

219

1.28

0.58

1.2

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

446

1.19

0.58

1.3

1.5

—

(3037756) Immunofixation for Serum or Plasma

307

3284

0.93

0.57

1.9

1.7

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.71

0.57

1.0

1.1

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

123

1.38

0.57

1.4

1.6

4.57

3.99

mg/l

0.14

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

123

1.38

0.57

1.4

1.6

0.72

0.66

mg/l

0.07

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

123

1.38

0.57

1.4

1.6

2.03

1.83

mg/l

0.09

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

356

1.21

0.56

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

192

1764

1.09

0.55

2.4

36.24

26.27

iu/ml

0.38

194

(3011841) English Walnut IgE Ab [Units/volume] in Serum

159

1.32

0.55

1.0

1.1

5.33

5.27

u/ml

0.00

125

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.41

0.54

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

121

1090

1.11

0.53

1.2

1.3

77.34

87.98

u/l

0.94

104

920

(3033923) Metanephrine [Moles/time] in 24 hour Urine

331

1.21

0.53

1.2

1.1

2.61

0.66

umol/24h

0.47

153

(3013762) Body weight Measured

1.54

0.53

1.3

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

470

1.17

0.52

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

470

1.17

0.52

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

470

1.17

0.52

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

470

1.17

0.52

1.1

—

(3027945) Reticulocytes/Erythrocytes in Blood

1748

17914

0.97

0.51

2.3

2.6

1.66

1.79

7.70

1533

16088

(3011335) Digoxin [Mass/volume] in Serum or Plasma

100

0.60

0.51

2.2

0.60

0.61

ug/l

—

100

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

978

0.89

0.50

3.0

2.8

41.06

38.84

0.44

547

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1020

0.89

0.49

6.9

7.1

45.87

96.93

ug/l

0.47

658

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

179

1653

1.08

0.48

1.7

1.4

3.46

3.90

ug/l

0.37

155

1391

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

475

4979

0.95

0.48

1.3

217.71

221.83

miu/ml

0.10

234

2235

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.45

0.48

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.45

0.48

1.0

0.02

0.07

u/ml

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

268

2516

1.07

0.47

1.5

1.4

0.32

0.36

nmol/l

0.79

204

1850

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

309

1.20

0.46

1.0

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1652

16907

0.97

0.45

3.9

4.4

12.23

24.98

ug/l

1.30

1266

13743

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

117

0.68

0.45

2.4

5.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

339

3215

1.06

0.44

1.2

1.3

253.60

267.85

u/ml

0.40

220

2009

(3017315) Amylase [Enzymatic activity/volume] in Urine

847

1.11

0.44

1.3

1.2

304.48

383.41

u/l

0.39

776

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

672

0.88

0.43

1.0

1.1

103.54

95.60

1.06

537

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

658

1.13

0.43

2.3

2.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

442

4622

0.96

0.42

1.7

2.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

337

3548

0.95

0.42

1.5

1.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

124

1136

1.09

0.42

1.0

772.98

740.45

ng/l

0.30

802

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

595

0.87

0.41

2.7

0.60

0.61

mmol/l

0.28

595

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.41

0.0

1.1

—

293.27

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

108

985

1.10

0.41

1.4

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.41

0.0

1.2

—

36.42

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.41

0.0

2.5

—

8.68

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

124

1139

1.09

0.40

1.0

37.89

42.08

ng/l

0.70

821

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.40

0.0

1.2

—

69.04

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.40

0.0

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

320

3044

1.05

0.39

1.2

1.5

146.73

151.14

au/ml

0.31

120

845

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

264

2499

1.06

0.39

1.3

0.58

2.45

nmol/l

1.30

250

2412

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

781

0.90

0.39

1.5

1.8

0.87

2.90

u/field

4.84

560

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

123

1133

1.09

0.38

1.0

285.15

329.43

ng/l

1.52

831

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

148

1374

1.08

0.38

1.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

148

1374

1.08

0.38

1.8

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

148

1374

1.08

0.38

1.8

1.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.38

0.38

14.6

8.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

675

0.89

0.38

1.1

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1041

0.91

0.38

1.6

1.5

7.48

6.68

u/l

0.23

822

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

312

2971

1.05

0.37

1.2

497.67

302.12

titre

0.40

233

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.32

0.37

1.4

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

136

0.74

0.37

1.7

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

112

0.71

0.37

1.5

1.9

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

746

0.90

0.36

1.1

8.90

12.35

u/ml

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

418

0.86

0.36

1.1

0.90

12.17

u/ml

0.78

233

(3023520) Reticulocytes [#/volume] in Blood

1361

13902

0.98

0.35

2.3

2.6

66.68

70.28

e9/l

3.63

945

10240

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

164

1536

1.07

0.35

4.7

5.4

39.04

102.20

u/ml

3.35

501

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

489

1.13

0.35

1.0

0.34

0.70

u/ml

0.81

477

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

189

0.79

0.34

1.9

1.8

1.68

1.72

mg/l

0.04

161

(3008536) Aspergillus sp Ab [Presence] in Serum

340

0.85

0.33

3.1

2.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

329

0.85

0.33

2.5

2.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

109

1.28

0.33

1.0

1.1

7.79

11.13

u/l

0.66

109

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

109

1.28

0.33

1.3

0.87

1.06

ml/s/173m2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.68

0.33

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

128

1193

1.07

0.32

1.4

1.5

21.57

23.67

u/ml

0.17

218

(44813793) Dust mix specific IgE antibody measurement

129

1203

1.07

0.32

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

128

1.25

0.31

1.8

2.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

229

2178

1.05

0.31

1.3

0.27

0.20

nmol/l

0.35

176

1692

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

108

1002

1.08

0.31

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

138

1293

1.07

0.31

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

230

1.17

0.30

2.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.71

0.30

5.7

5.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4058

40973

0.99

0.29

2.3

2.4

2.59

2.78

mg/l

6.10

3338

35591

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

107

0.75

0.29

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

211

2009

1.05

0.28

1.1

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

464

4789

0.97

0.28

3.5

3.3

3.40

3.53

ratio

0.03

252

2743

(3016031) Almond IgE Ab [Units/volume] in Serum

112

1.25

0.28

1.1

1.0

0.07

0.58

u/ml

—

(3001729) Color of Synovial fluid

117

0.77

0.27

1.6

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

127

1194

1.06

0.27

3.9

3.6

103.10

163.20

nmol/l

1.74

127

1182

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1567

15917

0.98

0.26

2.4

2.3

0.23

0.21

g/l

12.40

1459

14912

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

187

1.18

0.26

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1107

10864

1.02

0.26

3.2

3.5

4.52

4.47

pmol/l

1.03

960

9794

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

406

3933

1.03

0.26

1.4

1.5

107.45

154.64

pmol/l

1.71

397

3835

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.23

0.25

1.0

1.1

8.34

8.51

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

742

1.08

0.25

1.1

168.23

187.07

iu/ml

0.17

733

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.22

0.25

1.0

1.1

37.61

36.47

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.22

0.25

1.0

1.1

23.34

20.77

—

(3017704) Immunofixation for Urine

799

0.93

0.25

1.9

1.7

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

170

0.82

0.25

2.1

3.3

0.71

1.09

mg/l

—

121

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

129

1364

0.95

0.24

1.5

1.8

3.24

3.85

mg/l

2.04

123

1313

(3034426) Prothrombin time (PT)

522

1.09

0.24

1.1

1.2

27.21

28.31

1.11

522

(4281824) Cell count and differential, peritoneal fluid

188

1966

0.96

0.24

1.1

—

(3013466) aPTT in Blood by Coagulation assay

0.71

0.24

1.2

1.1

35.57

36.59

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

158

0.82

0.23

1.9

1.7

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

176

1842

0.96

0.23

1.3

1.2

41.40

30.93

nmol/l

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.24

0.22

1.2

1.1

26.20

23.16

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.24

0.22

1.2

1.1

38.60

25.02

u/ml

—

(3002079) Sodium [Moles/time] in 24 hour Urine

805

0.93

0.22

1.3

1.2

145.03

161.24

mmol/24h

1.30

805

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

153

1.18

0.22

1.0

1.1

0.02

1.83

u/ml

1.97

123

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

153

1.18

0.22

1.0

0.03

0.10

u/ml

0.96

101

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

144

1.18

0.22

1.0

1.1

105.41

94.22

titre

0.15

144

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.21

0.0

1.0

—

21.09

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

196.73

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

17.36

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

39.11

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

104

0.77

0.21

1.0

—

(21494814) CD8 cells/Lymphocytes in Specimen

643

1.07

0.21

1.8

2.1

31.67

31.24

0.09

643

(3032868) Hemoglobin electrophoresis panel in Blood

145

0.83

0.21

1.7

1.5

—

(3009410) PHENobarbital [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

7.5

—

91.50

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(36660577) Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method

0.00

0.21

0.0

1.4

—

84.50

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.25

0.20

1.1

—

22.15

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

193

1856

1.04

0.20

1.2

52.55

63.29

u/l

3.91

173

1618

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.20

0.0

1.0

—

(3026906) Gabapentin [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

82.71

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

365

0.90

0.19

1.3

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

685

0.93

0.19

1.7

1.6

3993.85

3316.70

titre

0.29

109

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

549

1.07

0.19

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

8348

83795

0.99

0.19

3.5

3.9

0.00

estimate

0.06

858

17658

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

303

2946

1.03

0.18

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

303

2946

1.03

0.18

1.2

1.3

—

(3003577) Lead [Moles/volume] in Blood

132

0.83

0.18

2.3

1.3

0.22

0.16

umol/l

—

(3009261) Glucose [Presence] in Urine by Test strip

8567

85374

1.01

0.17

3.6

4.0

0.00

0.29

estimate

1.86

847

17113

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

281

1.10

0.17

1.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

176

1.14

0.17

1.1

1.5

6.34

7.05

mmol/l

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1269

12535

1.01

0.17

3.0

4.0

72.63

88.75

ng/l

15.35

1108

10883

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1046

10602

0.99

0.17

8.4

10.1

1.20

1.33

4.13

1041

10538

(3000991) Gas panel - Venous blood

1414

13980

1.01

0.17

7.1

9.4

—

(3006598) pH of Arterial cord blood

0.75

0.17

1.0

1.1

—

(40768441) Liver Pathology biopsy report

122

1273

0.96

0.16

1.5

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

120

0.83

0.16

1.1

—

(40758358) Immune stain study

1.16

0.16

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

263

2558

1.03

0.16

1.3

0.14

0.23

nmol/l

1.50

175

(3020393) Adenovirus Ag [Presence] in Stool

158

1.14

0.16

1.1

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4585

45606

1.01

0.16

2.8

3.1

748.41

1179.76

ng/l

28.09

3753

39286

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

183

0.87

0.16

1.4

1.2

69.81

68.60

ug/l

0.02

183

(3010937) Rubella virus Ab [Presence] in Serum

1.20

0.16

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

689

0.94

0.16

2.7

2.4

51.17

51.99

umol/l

0.08

602

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

408

4166

0.98

0.15

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.77

0.15

1.0

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

248

2413

1.03

0.15

1.1

1.47

1.51

g/l

0.80

224

2203

(3022229) Phosphate [Moles/volume] in Urine

1.20

0.15

1.3

2.0

14.26

18.22

mmol/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

606

0.94

0.15

1.4

85.29

222.84

nmol/24h

1.72

606

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.13

0.15

1.0

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

751

1.05

0.15

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

751

1.05

0.15

1.4

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

978

9659

1.01

0.15

8.1

10.0

24.39

24.28

mmol/l

0.59

951

9496

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.08

0.14

1.2

1.6

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.80

0.14

1.3

1.5

816.27

478.55

nmol/l

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

150

1.13

0.14

1.0

0.19

0.68

u/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

335

3423

0.98

0.14

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

326

0.92

0.14

2.1

18.13

16.50

umol/l

0.51

326

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

243

0.91

0.13

1.2

102.77

120.03

ng/l

0.13

158

(3012898) Urea [Moles/volume] in Urine

170

0.88

0.13

1.4

1.5

260.27

166.85

mmol/l

1.43

151

(3027008) Opiates [Presence] in Urine

605

5960

1.02

0.13

1.6

1.9

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

190

0.89

0.13

1.0

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

293

0.92

0.12

3.8

3.1

50.52

43.60

1.01

293

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

292

0.92

0.11

7.6

6.2

7.22

8.64

0.63

292

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.16

0.11

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

472

4787

0.99

0.10

1.8

2.0

4.07

12.14

iu/l

1.09

153

1985

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1860

18479

1.01

0.10

4.8

4.6

232.55

243.33

u/l

3.56

1733

17601

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

241

1.08

0.10

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

820

1.04

0.10

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

275

2798

0.98

0.09

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.15

0.09

1.0

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

615

1.04

0.09

1.9

2.0

477.70

28282.24

u/ml

—

(3000764) Benzodiazepines [Presence] in Urine

599

5926

1.01

0.09

1.6

2.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

184

1.09

0.09

1.5

1.2

4.83

6.42

mmol/l

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

942

9344

1.01

0.09

3.2

3.8

52.53

59.86

u/ml

0.20

913

9038

(3028300) Cannabinoids [Presence] in Urine

604

5978

1.01

0.08

1.6

2.0

—

(3037121) Protein [Mass/volume] in Urine

542

5361

1.01

0.08

2.8

3.4

642.65

426.52

mg/l

0.26

212

2403

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

133

1298

1.02

0.08

1.2

1.3

1.15

1.81

u/ml

0.80

753

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.77

0.08

1.0

1.1

1.39

1.30

mom

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

533

5275

1.01

0.08

1.6

938.64

1006.12

mu/l

1.26

431

4392

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.04

0.08

2.7

10.6

98.57

104.99

g/l

—

(3013862) HLA-DP [Type]

1.04

0.08

1.0

—

(40765096) Chromosome analysis panel by Banding

490

1.04

0.07

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.82

0.07

1.0

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.05

0.07

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.05

0.07

1.1

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.02

0.07

1.1

8.12

8.24

mmol/l

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

195

1920

1.02

0.06

3.4

3.6

4.39

12.50

nmol/l

1.26

185

1857

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

878

1.03

0.06

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

138

1.09

0.06

1.3

1.2

103.57

111.81

ug/l

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

520

5243

0.99

0.06

1.6

1.7

267.58

300.98

mu/l

2.80

479

4757

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

943

9375

1.01

0.06

2.9

4.3

24.37

24.25

mmol/l

0.80

931

9272

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

711

1.03

0.06

1.4

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

791

1.02

0.05

1.6

2.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

268

1.04

0.04

1.3

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

535

5383

0.99

0.04

3.5

3.4

34.28

43.77

mg/l

0.97

486

4556

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

150

0.93

0.04

5.5

2.8

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

231

0.95

0.04

1.4

1.6

108.07

114.04

ug/l

0.08

196

(3018001) Oat IgE Ab [Units/volume] in Serum

111

1.08

0.04

1.0

0.18

0.27

u/ml

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

498

4952

1.01

0.04

2.2

2.6

3.51

3.59

g/l

0.65

469

4737

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

408

1.03

0.03

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

159

1574

1.01

0.03

2.7

3.3

24.62

13.81

index

0.52

901

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

360

1.03

0.03

4.4

3.1

103.94

113.73

ng/l

0.10

155

(3034770) Mitochondria Ab [Titer] in Serum

494

4919

1.00

0.02

1.3

1.2

750.00

968.05

titre

—

154

(3027944) Amphetamines [Presence] in Urine

586

5882

1.00

0.02

1.6

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7421

74259

1.00

0.02

2.5

2.8

—

estimate

—

(3050794) Legionella sp Ab [Presence] in Serum

158

0.95

0.02

1.0

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8414

84186

1.00

0.02

6.1

6.8

11.27

11.26

umol/l

0.02

7945

80379

(3028707) Methadone [Presence] in Urine by Screen method

256

2545

1.01

0.02

2.1

2.7

—

(3016879) Cocaine [Presence] in Urine

552

5535

1.00

0.01

1.7

2.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

678

0.99

0.01

1.7

0.85

2.45

u/ml

1.82

181

(3007566) Smooth muscle Ab [Titer] in Serum

497

4980

1.00

0.01

1.3

1.2

178.18

126.72

titre

0.26

476

(21494567) Legionella sp IgM Ab [Presence] in Serum

124

1.05

0.00

1.0

1.1

—

0.23

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

186

0.97

0.00

1.1

1.5

4.12

4.76

nmol/l

0.33

178

(3034860) Kappa light chains.free [Mass/volume] in Serum

538

5388

1.00

0.00

3.5

3.4

36.89

60.35

mg/l

1.60

483

4566

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

100

1006

0.99

0.00

1.5

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.05

0.00

2.1

2.4

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

138

1.01

0.00

1.1

1.0

—

7.13

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

110

1.00

0.00

1.0

—

(3002619) Bacteria identified in Specimen by Culture

429

1.00

0.00

1.1

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

522

1.00

0.00

1.1

1.2

—

(44806071) Cardiolipin IgM antibody measurement

225

0.98

0.00

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

743

1.00

0.00

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

239

1.00

0.00

1.1

1.2

72.08

62.16

ug/l

1.10

239

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

155

1.03

0.00

1.1

2.27

1.67

umol/24h

0.34

155

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

120

1.00

0.00

1.1

1.2

51.04

43.00

mg/l

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

181

0.99

0.00

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

467

1.01

0.00

1.7

9.93

9.07

ug/l

0.65

467

(3018851) Theophylline [Moles/volume] in Serum or Plasma

133

0.98

0.00

2.2

1.7

39.62

45.56

umol/l

0.43

133

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

25.71

—

(40760410) HLA-B [Type] by High resolution

0.90

0.00

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.0

—

44.57

—

(46236302) HLA-C [Type] by High resolution typing

0.90

0.00

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.90

0.00

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.2

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

4.0

—

137.17

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

1.3

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

6.3

—

9.50

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

0.05

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.1

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.4

—

19.77

—

(40763590) HLA-DQ beta [Type]

0.91

-0.00

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.1

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

2.3

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.94

-0.00

1.0

1.9

2.02

3.70

nmol/l

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_SPIROCHAETAL – Other spirochaetal diseases

GWS hits: 3

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other spirochaetal diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other spirochaetal diseases (AB1_OTHER_SPIROCHAETAL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints